Home
  >  
Section 42

EurekaMag Full Text Articles Chapter 41,999



References:

Bovenberg, R.A.; Burbach, J.P.; Wiegant, V.M.; Veeneman, G.H.; van Boom, J.H.; Baas, P.D.; Jansz, H.S.; de Wied, D. 1986: Gamma-Endorphin and schizophrenia: amino acid composition of gamma-endorphin and nucleotide sequence of gamma-endorphin cDNA from pituitary glands of schizophrenic patients. Brain Research 376(1): 29-37
Lebouille, J.L.; Burbach, J.P.; de Kloet, E.R. 1985: Gamma-Endorphin generating endopeptidase in rat brain: subcellular and regional distribution. Biochemical and Biophysical Research Communications 127(1): 44-48
Lebouille, J.L.; Burbach, J.P.; De Kloet, E.R.; Rommerts, F.F. 1986: Gamma-Endorphin-generating endopeptidase: distribution in body tissues and cellular localization in rat testis. Endocrinology 118(1): 372-376
Galivan, J.; Inglese, J.; McGuire, J.J.; Nimec, Z.; Coward, J.K. 1985: Gamma-Fluoromethotrexate: synthesis and biological activity of a potent inhibitor of dihydrofolate reductase with greatly diminished ability to form poly-gamma-glutamates. Proceedings of the National Academy of Sciences of the United States of America 82(9): 2598-2602
De Avila Barcelos, J.; Weigt, U. 1986: Gamma-GT activity in cow's milk during an udder function cycle in relation to processes in the mammary gland tissue. Zentralblatt für Veterinarmedizin. Reihe a 33(4): 308-319
Harano, K.; Harano, T.; Kutlar, F.; Huisman, T.H. 1985: Gamma-Globin gene triplication and quadruplication in Japanese newborns. Evidence for a decreased in vivo expression of the 3'-A gamma-globin gene. Febs Letters 190(1): 45-49
Mizoguchi, H.; Orlowski, M.; Wilk, S.; Green, J.P. 1979: Gamma-Glutamyl DOPA and gamma-glutamyl dopamine: effect on plasma glucose levels. European Journal of Pharmacology 57(2-3): 239-245
Bridges, R.J.; Meister, A. 1985: Gamma-Glutamyl amino acids. Transport and conversion to 5-oxoproline in the kidney. Journal of Biological Chemistry 260(12): 7304-7308
Roncaglioni, M.C.; Dalessandro, A.P.; Casali, B.; Vermeer, C.; Donati, M.B. 1986: Gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant. Haemostasis 16(3-4): 295-299
Wilk, S.; Mizoguchi, H.; Orlowski, M. 1978: Gamma-Glutamyl dopa: a kidney-specific dopamine precursor. Journal of Pharmacology and Experimental Therapeutics 206(1): 227-232
Ylikorkala, O.; Stenman, U.H.; Halmesmäki, E. 1987: Gamma-Glutamyl transferase and mean cell volume reveal maternal alcohol abuse and fetal alcohol effects. American Journal of Obstetrics and Gynecology 157(2): 344-348
Ahmad, S.; Okine, L.; Wood, R.; Aljian, J.; Vistica, D.T. 1987: Gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents. Journal of Cellular Physiology 131(2): 240-246
Kohdaira, T.; Iwasaki, A.; Iwamoto, T.; Konno, M. 1986: Gamma-Glutamyl transpeptidase (gamma-GTP) activity in human semen and its source. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 77(3): 428-431
Dass, P.D.; Donahue, M.J. 1986: Gamma-Glutamyl transpeptidase activity in Ascaris suum. Molecular and Biochemical Parasitology 20(3): 233-236
Ishii, H.; Ebihara, Y.; Okuno, F.; Munakata, Y.; Takagi, T.; Arai, M.; Shigeta, S.; Tsuchiya, M. 1986: Gamma-Glutamyl transpeptidase activity in liver of alcoholics and its localization. Alcoholism Clinical and Experimental Research 10(1): 81-85
Thusu, N.; Raina, P.N.; Johri, R.K. 1991: Gamma-Glutamyl transpeptidase activity in mice: age dependent changes and effect of cortisol. Indian Journal of Experimental Biology 29(12): 1124-1126
Murray, G.I.; Burke, M.D.; Ewen, S.W. 1987: Gamma-Glutamyl transpeptidase demonstrated in tissue sections embedded in glycol methacrylate resin. Histochemical Journal 19(9): 476-482
Gordon, J.A.; Gattone, V.H.; Schoolwerth, A.C. 1986: Gamma-Glutamyl transpeptidase excretion in cisplatin-induced acute renal failure. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 8(1): 18-25
Tate, S.S.; Meister, A. 1985: Gamma-Glutamyl transpeptidase from kidney. Methods in Enzymology 113: 400-419
Yates, C.M.; Butterworth, J.; Gordon, A. 1989: Gamma-Glutamyl transpeptidase in dementia. Neurobiology of Aging 10(1): 107-108
Suzuki, Y.; Ishizuka, H.; Kaneda, H.; Taniguchi, N. 1987: Gamma-Glutamyl transpeptidase in rat liver during 3'-Me-DAB hepatocarcinogenesis: immunohistochemical and enzyme histochemical study. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 35(1): 3-7
Chen, Y.F.; Huang, J.K.; Liu, S.F.; Wang, J.X. 1989: Gamma-Glutamyl transpeptidase localization in esophageal exfoliative cytology of a chinese population at risk for carcinoma. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 190(2): 170-173
Singh, J.; Chander, J.; Singh, S.; Singh, G.; Atal, C.K. 1986: Gamma-Glutamyl transpeptidase: a novel biochemical marker in inflammation. Biochemical Pharmacology 35(21): 3753-3760
Pawlak, A.; Lahuna, O.; Bulle, F.; Suzuki, A.; Ferry, N.; Siegrist, S.; Chikhi, N.; Chobert, M.N.; Guellaen, G.; Laperche, Y. 1988: Gamma-Glutamyl transpeptidase: a single copy gene in the rat and a multigene family in the human genome. Journal of Biological Chemistry 263(20): 9913-9916
Allison, R.D. 1985: Gamma-Glutamyl transpeptidase: kinetics and mechanism. Methods in Enzymology 113: 419-437
Colloredo-Mels, G.; Bettale, G.; Bellati, G.; Guanziroli, M.; Bertone, V.; Angeli, G.; Idéo, G. 1988: Gamma-Glutamyl-transpeptidase in diabetics: a case control study. Clinica Chimica Acta; International Journal of Clinical Chemistry 175(2): 189-195
Piacentini, M.; Beninati, S. 1988: Gamma-Glutamylamine derivatives in isolated rat hepatocyte proteins. Biochemical Journal 249(3): 813-817
Reichelt, K.L.; Poulsen, E. 1992: Gamma-Glutamylaminotransferase and transglutaminase in subcellular fractions of rat cortex and in cultured astrocytes. Journal of Neurochemistry 59(2): 500-504
Meister, A. 1985: Gamma-Glutamylcyclotransferase from rat kidney. Methods in Enzymology 113: 438-445
York, M.J.; Crossley, M.J.; Hyslop, S.J.; Fisher, M.L.; Kuchel, P.W. 1989: Gamma-Glutamylcyclotransferase: inhibition by D-beta-aminoglutaryl-L-alanine and analysis of the solvent kinetic isotope effect. European Journal of Biochemistry 184(1): 97-101
Newton, G.L.; Javor, B. 1985: Gamma-Glutamylcysteine and thiosulfate are the major low-molecular-weight thiols in halobacteria. Journal of Bacteriology 161(1): 438-441
Weinreich, D. 1979: Gamma-Glutamylhistamine: a major product of histamine metabolism in ganglia of the marine mollusk. Aplysia californica. Journal of Neurochemistry 32(2): 363-369
Faribault, G.; Wiebkin, P.; Hamilton, J.W.; Longnecker, D.S.; Curphey, T.J. 1987: Gamma-Glutamyltransferase activity in atypical acinar cell nodules of rat pancreas. Toxicology and Applied Pharmacology 88(3): 338-345
Zhu, S.G.; McGeer, E.G.; McGeer, P.L. 1990: Gamma-Glutamyltransferase activity is unchanged in acutely quinolinate-lesioned rat neostriatum but is elevated in Huntington's disease caudate. Experimental Neurology 107(1): 106-109
Varga, V.; Török, K.; Feuer, L.; Gulyás, J.; Somogyi, J. 1985: Gamma-Glutamyltransferase in the brain and its role in formation of gamma-L-glutamyl-taurine. Progress in Clinical and Biological Research 179: 115-125
Cartlidge, P.H.; Rutter, N. 1987: Gamma-Glutamyltransferase in the newborn. Early Human Development 15(4): 213-216
Gennari, P.; Naldi, M.; Motta, R.; Nucci, M.C.; Giacomini, C.; Violante, F.S.; Raffi, G.B. 1992: Gamma-Glutamyltransferase isoenzyme pattern in workers exposed to tetrachloroethylene. American Journal of Industrial Medicine 21(5): 661-671
Siest, G.; Schiele, F.; Muller, J.; Wellman, M. 1988: Gamma-Glutamyltransferase reference material: an example of international cooperation. Clinica Chimica Acta; International Journal of Clinical Chemistry 173(1): 19-26
McGeer, E.G.; Singh, E.A.; McGeer, P.L. 1987: Gamma-Glutamyltransferase: normal cortical levels in Alzheimer disease. Alzheimer Disease and Associated Disorders 1(1): 38-42
Russo, S.A.; Greengard, O. 1989: Gamma-Glutamyltranspeptidase activity in intact leukocytes: flow cytometric analysis and sorting. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 37(3): 323-330
Isacsson, G.; Andersson, G. 1985: Gamma-Glutamyltranspeptidase activity of rat submandibular gland after pilocarpine stimulation. Swedish Dental Journal 9(4): 171-174
Ivanov, S.; Kolínská, J.; Kraml, J.; Chelibonova-Lorer, H. 1992: Gamma-Glutamyltranspeptidase and dipeptidyl peptidase IV activity in the serum of normal and hepatoma-bearing chickens and in the plasma membranes from liver and hepatoma Mc-29. Cancer Biochemistry Biophysics 13(1): 43-49
Sinha, S.; Marshall, C.J.; Neal, G.E. 1986: Gamma-Glutamyltranspeptidase and the ras-induced transformation of a rat liver cell line. Cancer Research 46(3): 1440-1445
Suzuki, H.; Kumagai, H.; Tochikura, T. 1986: Gamma-Glutamyltranspeptidase from Escherichia coli K-12: formation and localization. Journal of Bacteriology 168(3): 1332-1335
Suzuki, H.; Kumagai, H.; Tochikura, T. 1986: Gamma-Glutamyltranspeptidase from Escherichia coli K-12: purification and properties. Journal of Bacteriology 168(3): 1325-1331
Sulakhe, S.J. 1987: Gamma-Glutamyltranspeptidase in dimethylbenz[a]anthracene-induced mammary adenocarcinomas and in livers of tumor bearing rats. International Journal of Biochemistry 19(6): 509-515
Kretzschmar, M.; Klinger, W. 1989: Gamma-Glutamyltranspeptidase in liver homogenates of rats of different ages: enzyme kinetics and age course of Km and Vmax. Zeitschrift für Versuchstierkunde 32(1): 41-47
Day, B.J.; Carlson, G.P.; DeNicola, D.B. 1990: Gamma-Glutamyltranspeptidase in rat bronchoalveolar lavage fluid as a probe of 4-ipomeanol and alpha-naphthylthiourea-induced pneumotoxicity. Journal of Pharmacological Methods 24(1): 1-8
Stenius, U.; Högberg, J. 1988: Gamma-Glutamyltranspeptidase-conferred resistance to hydroquinone induced GSH depletion and toxicity in isolated hepatocytes. Carcinogenesis 9(7): 1223-1227
Yeldandi, A.V.; Subbarao, V.; Rajan, A.; Reddy, J.K.; Rao, M.S. 1989: Gamma-Glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acetylaminofluorene administration. Carcinogenesis 10(4): 797-799
Stenius, U.; Rubin, K.; Gullberg, D.; Högberg, J. 1990: Gamma-Glutamyltranspeptidase-positive rat hepatocytes are protected from GSH depletion, oxidative stress and reversible alterations of collagen receptors. Carcinogenesis 11(1): 69-73
Snead, O.C. 1988: Gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models. Epilepsia 29(4): 361-368
Kozhechkin, S.N. 1979: Gamma-Hydroxybutyrate potentiates the action of dopamine. Neuropharmacology 18(11): 917-920
Hechler, V.; Bourguignon, J.J.; Wermuth, C.G.; Mandel, P.; Maitre, M. 1985: Gamma-Hydroxybutyrate uptake by rat brain striatal slices. Neurochemical Research 10(3): 387-396
Dyer, J.E. 1991: Gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity. American Journal of Emergency Medicine 9(4): 321-324
Snead, O.C.; Nichols, A.C. 1987: Gamma-Hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel. Neuropharmacology 26(10): 1519-1523
Snead, O.C.; Nichols, A.C.; Liu, C.C. 1992: Gamma-Hydroxybutyric acid binding sites: interaction with the GABA-benzodiazepine-picrotoxin receptor complex. Neurochemical Research 17(2): 201-204
Snead, O.C. 1987: Gamma-Hydroxybutyric acid in subcellular fractions of rat brain. Journal of Neurochemistry 48(1): 196-201
Osorio, I.; Davidoff, R.A. 1979: Gamma-Hydroxybutyric acid is not a GABA-mimetic agent in the spinal cord. Annals of Neurology 6(2): 111-116
Snead, O.C. 1990: Gamma-Hydroxybutyric acid-induced seizures bear no relation to core temperature. Epilepsia 31(3): 253-258
Hamilton, T.A.; Rigsbee, J.E.; Scott, W.A.; Adams, D.O. 1985: Gamma-Interferon enhances the secretion of arachidonic acid metabolites from murine peritoneal macrophages stimulated with phorbol diesters. Journal of Immunology 134(4): 2631-2636
Strunk, R.C.; Cole, F.S.; Perlmutter, D.H.; Colten, H.R. 1985: Gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. Journal of Biological Chemistry 260(28): 15280-15285
Montaldo, P.G.; Carbone, R.; Ponzoni, M.; Cornaglia-Ferraris, P. 1992: Gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells. Cancer Research 52(18): 4960-4964
Koeffler, H.P.; Reichel, H.; Bishop, J.E.; Norman, A.W. 1985: Gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochemical and Biophysical Research Communications 127(2): 596-603
Süssmuth, R.; Widmann, A. 1979: Gamma-Irradiated ribosomes from Micrococcus radiodurans in a cell-free protein synthesizing system. Zeitschrift für Naturforschung. Section C Biosciences 34(7-8): 565-569
Vogel, F.S.; Kemper, L.A.; Jeffs, P.W.; Cass, M.W.; Graham, D.G. 1977: Gamma-L-Glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in Agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells. Cancer Research 37(4): 1133-1136
Tkachuk, R.; Mellish, V.J. 1977: Gamma-L-Glutamyl-L-cysteine: its isolation and identification from wheat germ. Canadian Journal of Biochemistry 55(4): 295-300
Worth, D.P.; Harvey, J.N.; Brown, J.; Lee, M.R. 1985: Gamma-L-Glutamyl-L-dopa is a dopamine pro-drug, relatively specific for the kidney in normal subjects. Clinical Science 69(2): 207-214
Ungerer, A.; Schmitz-Bourgeois, M.; Mélan, C.; Boulanger, Y.; Reinbolt, J.; Amiri, I.; de Barry, J. 1988: Gamma-L-glutamyl-L-aspartate induces specific deficits in long-term memory and inhibits [3H]glutamate binding on hippocampal membranes. Brain Research 446(2): 205-211
Tóth, S.; Csaba, G. 1988: Gamma-L-glutamyl-taurine (Litoralon) prevents the micronucleus formation induced by mitomycin C. Mutation Research 209(1-2): 85-89
Wainwright, P.; Ward, G.R.; Molnar, J.D. 1985: Gamma-Linolenic acid fails to prevent the effects of prenatal ethanol exposure on brain and behavioral development in B6D2F2 mice. Alcoholism Clinical and Experimental Research 9(4): 377-383
Klotz, A.V.; Glazer, A.N. 1987: Gamma-N-methylasparagine in phycobiliproteins. Occurrence, location, and biosynthesis. Journal of Biological Chemistry 262(36): 17350-17355
Takeda, Y.; Krause, J.E. 1989: Gamma-Preprotachykinin-(72-92)-peptide amide potentiates substance P-induced salivation. European Journal of Pharmacology 161(2-3): 267-271
Dam, T.V.; Takeda, Y.; Krause, J.E.; Escher, E.; Quirion, R. 1990: Gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin i gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proceedings of the National Academy of Sciences of the United States of America 87(1): 246-250
Colilla, F.J.; Rocher, A.; Mendez, E. 1990: Gamma-Purothionins: amino acid sequence of two polypeptides of a new family of thionins from wheat endosperm. Febs Letters 270(1-2): 191-194
Bleichrodt, J.F.; Roos-Verheij, W.S. 1979: Gamma-Ray mutagenesis in bacteriophage T4 is not enhanced by oxygen. Mutation Research 61(2): 121-127
Suzuki, N.; Okada, S. 1977: Gamma-Ray mutagenesis of cultured mammalian cells in vitro and in vivo. Mutation Research 43(1): 81-90
Fuse, H.; Masukagami, T.; Kataumi, Z.; Shimazaki, J. 1985: Gamma-Seminoprotein in serum of prostatic cancer. Hinyokika Kiyo. Acta Urologica Japonica 31(1): 81-85
Poulose, A.J.; Croteau, R. 1978: Gamma-Terpinene synthetase: a key enzyme in the biosynthesis of aromatic monoterpenes. Archives of Biochemistry and Biophysics 191(1): 400-411
Stevens, J.R.; Phillips, I.; de Beaurepaire, R. 1988: Gamma-Vinyl GABA in endopiriform area suppresses kindled amygdala seizures. Epilepsia 29(4): 404-411
Gram, L.; Klosterskov, P.; Dam, M. 1985: Gamma-Vinyl GABA: a double-blind placebo-controlled trial in partial epilepsy. Annals of Neurology 17(3): 262-266
Perry, T.L.; Kish, S.J.; Hansen, S. 1979: Gamma-Vinyl GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain. Journal of Neurochemistry 32(6): 1641-1645
Bertilsson, L.; Suria, A.; Costa, E. 1976: gamma-aminobutyric acid in rat superior cervical ganglion. Nature 260(5551): 540-541
Feddersen, J.C.; Gormsen, J. 1976: Gamma-dimerization, alpha-polymerization, and plasmin degradation of human fibrin. Effect of various inhibitors of factor XIIi on the patterns in SDS-electrophoresis and crossed immunoelectrophoresis. Thrombosis and Haemostasis 36(1): 27-36
Adam, S. 1977: Gamma-radiolysis of N2O-saturated aqueous solutions of trehalose and trehalose/amino acid mixtures. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 32(3): 219-227
Rouscilles, A.; Houee-Levin, C.; Gardes-Albert, M.; Ferradini, C. 1989: Gamma-radiolysis study of the reduction by COO- free radicals of daunorubicin intercalated in DNA. Free Radical Biology and Medicine 6(1): 37-43
Liang, C.C. 1988: Gamma-thalassemia and its related abnormalities in China. Hemoglobin 12(5-6): 717-721
Leong, C.H.; Ong, G.B. 1975: Gastrocystoplasty. British Journal of Urology 47(2): 236
Paddon, C.J.; Hinnebusch, A.G. 1989: Gcd12 mutations are gcn3-dependent alleles of GCD2, a negative regulator of GCN4 in the general amino acid control of Saccharomyces cerevisiae. Genetics 122(3): 543-550
Nguyen, L.M.; Niesor, E.; Bentzen, C.L. 1987: Gem-Diphosphonate and gem-phosphonate-phosphate compounds with specific high density lipoprotein inducing activity. Journal of Medicinal Chemistry 30(8): 1426-1433
García Aguilar, J.A.; Rodríguez Domínguez, J. 1979: General framework of a model for the evaluation of health programs. Salud Publica de Mexico 21(5): 593-601
Servín-González, L.; Ortiz, M.; González, A.; Bastarrachea, F. 1987: GlnA mutations conferring resistance to methylammonium in Escherichia coli K12. Journal of General Microbiology 133(6): 1631-1639
Castaño, I.; Bastarrachea, F.; Covarrubias, A.A. 1988: GltBDF operon of Escherichia coli. Journal of Bacteriology 170(2): 821-827
Barel, M.; Vazquez, A.; Charriaut, C.; Aufredou, M.T.; Galanaud, P.; Frade, R. 1986: Gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes. Febs Letters 197(1-2): 353-356
Müller, W.E.; Schröder, H.C.; Ushijima, H.; Dapper, J.; Bormann, J. 1992: Gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. European Journal of Pharmacology 226(3): 209-214
Frade, R.; Myones, B.L.; Barel, M.; Krikorian, L.; Charriaut, C.; Ross, G.D. 1985: Gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4). European Journal of Immunology 15(12): 1192-1197
Frade, R.; Barel, M.; Ehlin-Henriksson, B.; Klein, G. 1985: Gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proceedings of the National Academy of Sciences of the United States of America 82(5): 1490-1493
Delcayre, A.X.; Fiandino, A.; Barel, M.; Frade, R. 1987: Gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein. European Journal of Immunology 17(12): 1827-1833
Tamura, T.; Simon, E.; Niemann, H.; Snoek, G.T.; Bauer, H. 1986: Gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine. Molecular and Cellular Biology 6(12): 4745-4748
Merkle, R.K.; Helland, D.E.; Welles, J.L.; Shilatifard, A.; Haseltine, W.A.; Cummings, R.D. 1991: Gp160 of HIV-i synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing. Archives of Biochemistry and Biophysics 290(1): 248-257
Thomas, D.J.; Wall, J.S.; Hainfeld, J.F.; Kaczorek, M.; Booy, F.P.; Trus, B.L.; Eiserling, F.A.; Steven, A.C. 1991: Gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. Journal of Virology 65(7): 3797-3803
Carrel, S. 1991: Gp33-38, an early human T cell activation antigen. Journal of Immunology 146(6): 2072
Orlando, R.A.; Kerjaschki, D.; Kurihara, H.; Biemesderfer, D.; Farquhar, M.G. 1992: Gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proceedings of the National Academy of Sciences of the United States of America 89(15): 6698-6702
Schnitzer, J.E. 1992: Gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. American Journal of Physiology 262(1 Part 2): H246-H254
Donnelly, C.E.; Walker, G.C. 1989: GroE mutants of Escherichia coli are defective in umuDC-dependent UV mutagenesis. Journal of Bacteriology 171(11): 6117-6125
Suarez, H.G.; du Villard, J.A.; Caillou, B.; Schlumberger, M.; Parmentier, C.; Monier, R. 1991: Gsp mutations in human thyroid tumours. Oncogene 6(4): 677-679
Nakamura, S.; Nakamura, M.; Kojima, T.; Yoshida, H. 1989: GyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrobial Agents and ChemoTherapy 33(2): 254-255
Fasching, C.E.; Tenover, F.C.; Slama, T.G.; Fisher, L.M.; Sreedharan, S.; Oram, M.; Willard, K.; Sinn, L.M.; Gerding, D.N.; Peterson, L.R. 1991: GyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee. Journal of Infectious Diseases 164(5): 976-979
Contreras, A.; Maxwell, A. 1992: GyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. Molecular Microbiology 6(12): 1617-1624
Böhm, M.; Diet, F.; Pieske, B.; Erdmann, E. 1988: H-ANF does not play a role in the regulation of myocardial force of contraction. Life Sciences 43(16): 1261-1267
Zakut, H.; Birkenfeld, S.; Krispin, M. 1985: HCG as tumor marker in non-trophoblastic neoplasms. Harefuah 108(2): 82-85
Kadar, N.; Romero, R. 1987: HCG determinations in early pregnancy. Fertility and Sterility 47(4): 722-724
Cole, L.A.; Restrepo-Candelo, H.; Lavy, G.; Decherney, A. 1987: HCG free beta-subunit an early marker of outcome of in vitro fertilization clinical pregnancies. Journal of Clinical Endocrinology and Metabolism 64(6): 1328-1330
Kontoravdis, A.; Kassanos, D.; Chryssicopoulos, A.; Souchleri-Phocas, I.; Kilbassanis, H. 1987: HCG regression after treatment in active and regressed extrauterine pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology 26(3): 225-231
Purvis, K.; Torjesen, P.A.; Haug, E.; Hansson, V. 1977: HCG suppression of LH receptors and responsiveness of testicular tissue to hCG. Molecular and Cellular Endocrinology 8(1): 73-80
Kuhn, J.M.; Reznik, Y.; Mahoudeau, J.A.; Courtois, H.; Lefebvre, H.; Wolf, L.M.; Luton, J.P. 1989: HCG test in gynaecomastia: further study. Clinical Endocrinology 31(5): 581-590
Mancini, G.; Perona, M.; Dall'Amico, C.D.; Bollati, C.; Fulvia, A.; Carbonara, A.O. 1992: HCG, AFP, and uE3 patterns in the 14-20th weeks of Down's syndrome pregnancies. Prenatal Diagnosis 12(7): 619-624
Davies, T.F.; Platzer, M. 1986: HCG-induced TSH receptor activation and growth acceleration in FRTL-5 thyroid cells. Endocrinology 118(5): 2149-2151
Lee, C.Y. 1979: HCG-induced loss of LH-hCG receptor and desensitization of adenylate cyclase. Advances in Experimental Medicine and Biology 112: 717-722
Hammar, M.; Berg, A.A.; Kjessler, B. 1989: HCG-treatment alone is insufficient for restitution of spermatogenesis in a state with arrest at the spermatogonial level. Scandinavian Journal of Urology and Nephrology 23(4): 247-249
Fiscus, R.R.; Wang, X.; Hao, H. 1992: HCGRP8-37 antagonizes vasodilations and cAMP responses to rat CGRP in rat caudal artery. Annals of the new York Academy of Sciences 657: 513-515
Dennis, T.; Fournier, A.; Cadieux, A.; Pomerleau, F.; Jolicoeur, F.B.; St Pierre, S.; Quirion, R. 1990: HCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. Journal of Pharmacology and Experimental Therapeutics 254(1): 123-128
Prieto, J.C.; Serrano-Rios, M. 1976: HCS regulation during pregnancy. Obstetrics and Gynecology 48(3): 297-301
Morris, B.J. 1989: HGK-1: a kallikrein gene expressed in human prostate. Clinical and Experimental Pharmacology and Physiology 16(4): 345-351
Brown, G.; Daw, E. 1979: HPL concentrations. Obstetrics and Gynecology 54(4): 534
Zlatnik, F.J.; Varner, M.W.; Hauser, K.S.; Lee, S.S. 1979: HPL: physiologic and pathophysiologic observations. Obstetrics and Gynecology 54(3): 314-317
Reeve, J.; Bradbeer, J.N.; Arlot, M.; Davies, U.M.; Green, J.R.; Hampton, L.; Edouard, C.; Hesp, R.; Hulme, P.; Ashby, J.P. 1991: HPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses. Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the Usa 1(3): 162-170
Tomasetto, C.; Rio, M.C.; Gautier, C.; Wolf, C.; Hareuveni, M.; Chambon, P.; Lathe, R. 1990: HSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO Journal 9(2): 407-414
Hülsmann, W.C.; Brown, M.S.; Goldstein, J.L. 1986: He Nobel Prize for Medicine 1985: studies by M.S. Brown and J.L. Goldstein on (the lack of) control of cholesterol metabolism. Nederlands Tijdschrift Voor Geneeskunde 130(5): 195-197
Wroblewska, Z.; Savage, K.; Spivack, J.G.; Fraser, N.W. 1988: Herpes simplex virus infection accelerates the age-related reactivity of mouse trigeminal ganglia neurons with anti-mouse IgG antibody in immunostaining. Microbial Pathogenesis 5(4): 233-240
Williams, J.; Williams, K.M.; Marshall, T. 1990: Heterogeneity of creatine kinase isoenzyme MM in serum in myocardial infarction: interconversion of the "normal" and "abnormal" sub-bands by glutathione. Clinical Chemistry 36(5): 775-777
Banuett, F.; Hoyt, M.A.; McFarlane, L.; Echols, H.; Herskowitz, I. 1986: HflB, a new Escherichia coli locus regulating lysogeny and the level of bacteriophage lambda cIi protein. Journal of Molecular Biology 187(2): 213-224
Rudd, K.E.; Menzel, R. 1987: His operons of Escherichia coli and Salmonella typhimurium are regulated by DNA supercoiling. Proceedings of the National Academy of Sciences of the United States of America 84(2): 517-521
Voll, M.J.; Cohen, L.A.; Germida, J.J. 1979: His-Linked hydrogen sulfide locus of Salmonella typhimurium and its expression in Escherichia coli. Journal of Bacteriology 139(3): 1082-1084
Marvel, C.C.; Arps, P.J.; Rubin, B.C.; Kammen, H.O.; Penhoet, E.E.; Winkler, M.E. 1985: HisT is part of a multigene operon in Escherichia coli K-12. Journal of Bacteriology 161(1): 60-71
Derman, E.; Goldberg, S.; Darnell, J.E. 1976: HnRNA in Hela cells: distribution of transcript sizes estimated from nascent molecule profile. Cell 9(3): 465-472
Ghetti, A.; Piñol-Roma, S.; Michael, W.M.; Morandi, C.; Dreyfuss, G. 1992: HnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs. Nucleic Acids Research 20(14): 3671-3678
Yannopoulos, G.; Stamatis, N.; Monastirioti, M.; Hatzopoulos, P.; Louis, C. 1987: Hobo is responsible for the induction of hybrid dysgenesis by strains of Drosophila melanogaster bearing the male recombination factor 23.5MRF. Cell 49(4): 487-495
Ingleton, P.M.; Hunt, N.H.; Underwood, J.C.; Michelangeli, V.P.; Crawford, A.; Martin, T.J. 1976: hormone-responsive adenylate cyclase in a transplantable osteogenic sarcoma in the rat. Journal of Endocrinology 69(3): 26p-27p
Jonas, S. 1979: Hospitals adopt new role: Health promotion. Hospitals 53(19): 84-86
Ling, N.; Guillemin, R. 1986: HpGRF-44-NH2, lot no. 92-81-5G-41-47, is (human) growth hormone-releasing factor containing no trace of (ovine) corticotropin-releasing factor. Endocrinology 118(3): 1249-1251
Bode, V.C.; McDonald, J.D.; Guenet, J.L.; Simon, D. 1988: Hph-1: a mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics 118(2): 299-305
Albertini, R.J.; O'Neill, J.P.; Nicklas, J.A.; Recio, L.; Skopek, T.R. 1990: Hprt mutations in vivo in human T-lymphocytes: frequencies, spectra and clonality. Progress in Clinical and Biological Research 340c: 15-24
Medhurst, A.D.; Westwick, J.; Piper, P.J. 1991: HrIL-8-induced hyperresponsiveness in guinea pig perfused lungs. Annals of the new York Academy of Sciences 629: 419-421
Sargan, D.R.; Tsai, M.J.; O'Malley, B.W. 1986: Hsp108,,,,,, a novel heat shock inducible protein of chicken. Biochemistry 25(20): 6252-6258
Lam, K.T.; Calderwood, S.K. 1992: Hsp70 binds specifically to a peptide derived from the highly conserved domain (I) region of p53. Biochemical and Biophysical Research Communications 184(1): 167-174
Rattner, J.B. 1991: Hsp70 is localized to the centrosome of dividing Hela cells. Experimental Cell Research 195(1): 110-113
Miyagawa, K.; Sakamoto, H.; Yoshida, T.; Yamashita, Y.; Mitsui, Y.; Furusawa, M.; Maeda, S.; Takaku, F.; Sugimura, T.; Terada, M. 1988: Hst-1 transforming protein: expression in silkworm cells and characterization as a novel heparin-binding growth factor. Oncogene 3(4): 383-389
Kiselev, V.I. 1988: HtpR-like gene controls cell division and proteolysis in Pseudomonas aeruginosa. Biotechnology and Applied Biochemistry 10(6): 589-596
Torbett, B.E.; Picchio, G.; Mosier, D.E. 1991: Hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis. Immunological Reviews 124: 139-164
Lehmann, R.; Nüsslein-Volhard, C. 1987: Hunchback, a gene required for segmentation of an anterior and posterior region of the Drosophila embryo. Developmental Biology 119(2): 402-417
Farriaux, J.P.; Ghisolfi, J.; Navarro, J.; Putet, G.; Rey, J.; Ricour, C.; Rieu, D.; Vidailhet, M. 1988: Hydrolysed dietary preparations for infant feeding and prevention of allergy. Archives Francaises de Pediatrie 45(6): 435-437
Speleman, F.; De Potter, C.; Dal Cin, P.; Mangelschots, K.; Ingelaere, H.; Laureys, G.; Benoit, Y.; Leroy, J.; Van Den Berghe, H. 1990: I(12p) in a malignant ovarian tumor. Cancer Genetics and Cytogenetics 45(1): 49-53
Speleman, F.; Laureys, G.; Benoit, Y.; Cuvelier, C.; Suijkerbuijk, R.; De Jong, B. 1992: I(12p) in a near-diploid mature ovarian teratoma. Cancer Genetics and Cytogenetics 60(2): 216-218
Castedo, S.M.; de Jong, B.; Oosterhuis, J.W.; Seruca, R.; Idenburg, V.J.; Buist, J.; Sleijfer, D.T. 1988: I(12p)-negative testicular germ cell tumors. a different group?. Cancer Genetics and Cytogenetics 35(2): 171-178
Xiao, H.; Block, A.W.; Romano, J.; Dadley, B.; Han, T.; Sandberg, A.A. 1990: I(12q) in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 50(1): 171-172
Uike, N.; Yamashita, S.; Obama, K.; Takahira, H.; Nakai, H.; Inazawa, J.; Umemura, T.; Akashi, K.; Kozuru, M. 1992: I(17q) appearing in acute phase in Ph1-negative, BCR-negative CML. Japanese Journal of Clinical Hematology 33(5): 694-699
Bardi, G.; Johansson, B.; Pandis, N.; Békássy, A.N.; Kullendorff, C.M.; Hägerstrand, I.; Heim, S. 1991: I(8q) as the primary structural chromosome abnormality in a hepatoblastoma. Cancer Genetics and Cytogenetics 51(2): 281-283
Recher, H.; Willis, G.L.; Smith, G.C.; Copolov, D.L. 1988: I.r. Beta-endorphin, corticosterone, cholesterol and triglyceride concentrations in rat plasma after stress, cingulotomy or both. Pharmacology Biochemistry and Behavior 31(1): 75-79
Thöny, B.; Hwang, D.S.; Fradkin, L.; Kornberg, A. 1991: IciA, an Escherichia coli gene encoding a specific inhibitor of chromosomal initiation of replication in vitro. Proceedings of the National Academy of Sciences of the United States of America 88(10): 4066-4070
Allaoui, A.; Mounier, J.; Prévost, M.C.; Sansonetti, P.J.; Parsot, C. 1992: IcsB: a Shigella flexneri virulence gene necessary for the lysis of protrusions during intercellular spread. Molecular Microbiology 6(12): 1605-1616
Samuels, W.M. 1988: IiFAR: a new grassroots voice supporting the use of laboratory animals in research. Incurably ill for animal research. Physiologist 31(2): 22
Fayerman, J.T.; Vann, M.C.; Williams, L.S.; Umbarger, H.E. 1979: IlvU, a locus in Escherichia coli affecting the derepression of isoleucyl-tRNA synthetase and the RPC-5 chromatographic profiles of tRNAIle and tRNAVal. Journal of Biological Chemistry 254(19): 9429-9440
Biggar, W.D.; Good, R.A. 1975: Immunodeficiency in ataxia-telangiectasia. Birth Defects Original Article Series 11(1): 271-276
Barandum, S.; Morell, A.; Skvaril, F.; Keller, H. 1975: Immunoperturbation in paraproteinemia. Birth Defects Original Article Series 11(1): 95-98
Chambers, R.M. 1975: Impotence and urethral stricture. British Journal of Urology 47(2): 229-230
Kinlen, L.J. 1977: The epidemiology of leukaemias and lymphomas: a review. Proceedings of the Royal Society of Medicine 70(8): 553-556
Schechter, B.; Treves, A.J.; Feldman, M. 1975: In vitro destruction of 3LL tumor cells by syngeneic in vitro-sensitized lymphocytes. Israel Journal of Medical Sciences 11(12): 1396-1397
Kaden, J.; Adamczyk, G.; Eichler, C.; Strobelt, V.; Groth, J.; Janisch, W.; May, G. 1985: Incidence of cytomegalovirus infections following transplantation of kidneys from seropositive and seronegative donors. Zeitschrift für Urologie und Nephrologie 78(5): 267-271
Smeets, R.E.; Hoorntje, S.J. 1988: Incidence of impaired kidney function in 2050 patients admitted to a general hospital; a prospective study. Nederlands Tijdschrift Voor Geneeskunde 132(49): 2244-2247
Senèze, J. 1992: Infectious spondylodiscitis after genital prolapse cure. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 21(4): 448
Zablotskaĭte, D.P.; Iuriavichius, I.A.; Narushiavichius, E.V. 1985: Influence of Ca channel blockers on the positive inotropic effect of ionophore A23187 in the myocardium. Biulleten' Eksperimental'noi Biologii i Meditsiny 99(5): 571-573
Staab, E.V. 1991: InfoRAD at RSNA 1991. Radiographics: a Review Publication of the Radiological Society of North America Inc 11(5): 806
Staab, E.V. 1991: InfoRAD. Informatics in radiology. past and future. Radiographics: a Review Publication of the Radiological Society of North America Inc 11(2): 218
Sansone, R.; Sessarego, M.; Haupt, R.; Garré, M.L.; Strigini, P. 1989: Ins(6;1) in a patient with congenital leukemia. Cancer Genetics and Cytogenetics 37(1): 19-22
Donti, E.; Falini, B.; Bordoni, S.; Rosetti, A.; Carloni, I.; Donti, G.V. 1987: Ins(6;11) in a case of peripheral T-cell lymphoma. Cancer Genetics and Cytogenetics 27(2): 367-369
McMahon, A.P.; Moon, R.T. 1989: Int-1--a proto-oncogene involved in cell signalling. Development 107 Suppl: 161-167
Sato, K.; Kato, T.; Moriyama, M. 1992: Int-2 and c-erbB-2 gene amplification in urological cancers. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 83(12): 1957-1963
Clapp, N.K. 1978: Interactions of ionizing radiation, nitrosamines, sulfonoxyalkanes and antioxidants as they affect carcinogenesis and survival in mice. American Industrial Hygiene Association Journal 39(6): 448-453
Cirino, E.; Calì, V.; Fusto, A.; Pecorella, G. 1977: Intestinal occlusion caused by a phytobezoar. Minerva Chirurgica 32(11): 727-729
Pfeilschifter, J. 1991: Intracellular signal transmission. Schweizerische Rundschau für Medizin Praxis 80(48): 1339-1343
Inaba, T.; Hanada, R.; Nakashima, M.; Hayashi, Y.; Yamamoto, K.; Nishida, T. 1988: Inv(11) (p15q23) in a case of childhood myelodysplastic syndrome. Japanese Journal of Clinical Hematology 29(2): 189-194
Walter, T.A.; Fan, S.X.; Medchill, M.T.; Berger, C.S.; Decker, H.J.; Sandberg, A.A. 1989: Inv(12)(p11.2q13) in an endometrial polyp. Cancer Genetics and Cytogenetics 41(1): 99-103
Vargas-Moyeda, E.; Rivera, H.; Garcia-Cruz, D.; Moller, M.; Cantu, J.M. 1987: Inv(5)(p13q13) in a four generation pedigree. Journal de Genetique Humaine 35(4): 305-308
Jonas, O.; Smyth, N. 1975: Ipecacuanha-ipecauanha. Medical Journal of Australia 1(17): 534-535
Stening, S.G. 1975: Irradiation treatment of prostatic carcinoma. British Journal of Urology 47(2): 228
El Naggar, A.M.; El-Aswad, A.H.; Montasir, A.; Nasr, E.M. 1975: Irritable eye. Bulletin of the Ophthalmological Society of Egypt 68: 17-3o
Zicot, M. 1979: Is there a treatment for peripheral arterial insufficiency?. Revue Medicale de Liege 34(2): 48-51
Rapin, C.H.; Jung, A.; Lagier, R.; MacGee, W.; Barras, C.; Courvoisier, B.; Vasey, H.; Junod, J.P. 1979: Is there an osteomalacia component in femur neck fractures?. Schweizerische Medizinische Wochenschrift 109(47): 1894-1895
Gupta, R.C.; Dettbarn, W.D. 1987: Iso-OMPA-induced potentiation of soman toxicity in rat. Archives of Toxicology 61(1): 58-62
Ferrer, A.; Lloveras, J.; Codina, G.; Martín, N. 1987: Isolation of Legionella pneumophila in bone marrow. Medicina Clinica 88(8): 346-347
Mizrokhi, L.J.; Georgieva, S.G.; Ilyin, Y.V. 1988: Jockey, a mobile Drosophila element similar to mammalian LINEs, is transcribed from the internal promoter by RNA polymerase Ii. Cell 54(5): 685-691
Marx, J.L. 1988: Jun Is bustin' out all over. Science 242(4884): 1377-1378
Schütte, J.; Viallet, J.; Nau, M.; Segal, S.; Fedorko, J.; Minna, J. 1989: Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59(6): 987-997
Ryder, K.; Lanahan, A.; Perez-Albuerne, E.; Nathans, D. 1989: Jun-D: a third member of the jun gene family. Proceedings of the National Academy of Sciences of the United States of America 86(5): 1500-1503
Alcivar, A.A.; Hake, L.E.; Kwon, Y.K.; Hecht, N.B. 1991: JunD mRNA expression differs from c-jun and junB mRNA expression during male germinal cell differentiation. Molecular Reproduction and Development 30(3): 187-193
Brant, L.J.; Duncan, D.B.; Dixon, D.O. 1992: K-ratio t tests for multiple comparisons involving several treatments and a control. Statistics in Medicine 11(7): 863-873
DeWerd, L.A.; Ranallo, F. 1989: KVp cassette measurements. Radiologic Technology 61(2): 145-146
Chiappinelli, V.A.; Lee, J.C. 1985: Kappa-Bungarotoxin. Self-association of a neuronal nicotinic receptor probe. Journal of Biological Chemistry 260(10): 6182-6186
Wolf, K.M.; Ciarleglio, A.; Chiappinelli, V.A. 1988: Kappa-Bungarotoxin: binding of a neuronal nicotinic receptor antagonist to chick optic lobe and skeletal muscle. Brain Research 439(1-2): 249-258
Grant, G.A.; Chiappinelli, V.A. 1985: Kappa-Bungarotoxin: complete amino acid sequence of a neuronal nicotinic receptor probe. Biochemistry 24(6): 1532-1537
Leighton, G.E.; Rodriguez, R.E.; Hill, R.G.; Hughes, J. 1988: Kappa-Opioid agonists produce antinociception after I.v. and I.c.v. but not intrathecal administration in the rat. British Journal of Pharmacology 93(3): 553-560
Vink, R.; Portoghese, P.S.; Faden, A.I. 1991: Kappa-Opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury. American Journal of Physiology 261(6 Pt 2): R1527-R1532
Smith, J.A.; Loughlin, S.E.; Leslie, F.M. 1992: Kappa-Opioid inhibition of [3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Molecular Pharmacology 42(4): 575-583
Tai, K.K.; Bian, C.F.; Wong, T.M. 1992: Kappa-Opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sciences 51(12): 909-913
Levinson, S.S. 1991: Kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias. Clinical Chemistry 37(6): 1122-1126
Jagura-Burdzy, G.; Thomas, C.M. 1992: KfrA gene of broad host range plasmid RK2 encodes a novel DNA-binding protein. Journal of Molecular Biology 225(3): 651-660
Garcia, V.D.; Goldani, J.C. 1987: Kidney transplant: criteria for the selection of donors. AMB: revista da Associacao Medica Brasileira 33(9-10): 207-209
Teubner, E.; Gerstenberger, F.; Burgert, R. 1991: Kinematic consideration of the shoulder girdle and its consequences on common surgical methods. Der Unfallchirurg 94(9): 471-477
Young, C.; Prince, A.S.; Figurski, D.H. 1985: KorA function of promiscuous plasmid RK2: an autorepressor that inhibits expression of host-lethal gene kilA and replication gene trfA. Proceedings of the National Academy of Sciences of the United States of America 82(21): 7374-7378
Mack, K.J.; Cortner, J.; Mack, P.; Farnham, P.J. 1992: Krox 20 messenger RNA and protein expression in the adult central nervous system. Brain Research. Molecular Brain Research 14(1-2): 117-123
Iakhno, V.G. 1975: L model of a leading center. Biofizika 20(4): 669-674
Perrimon, N.; Mahowald, A.P. 1986: L(1)hopscotch, a larval-pupal zygotic lethal with a specific maternal effect on segmentation in Drosophila. Developmental Biology 118(1): 28-41
Ambrosio, L.; Mahowald, A.P.; Perrimon, N. 1989: L(1)pole hole is required maternally for pattern formation in the terminal regions of the embryo. Development 106(1): 145-158
Resnick, R.B.; Orlin, L.; Geyer, G.; Schuyten-Resnick, E.; Kestenbaum, R.S.; Freedman, A.M. 1976: L-Alpha-acetylmethadol (LAAM): prognostic considerations. American Journal of Psychiatry 133(7): 814-819
Leinweber, F.J.; Szpiech, J.M.; Di Carlo, F.J. 1978: L-Bunolol metabolism in rats: identification of urinary metabolites. Journal of Pharmaceutical Sciences 67(1): 129-131
Goa, K.L.; Brogden, R.N. 1987: L-Carnitine. a preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs 34(1): 1-24
Schwarzacher, S.; Raberger, G. 1992: L-NG-nitro-arginine methyl ester in the anesthetized rabbit: venous vasomotion and plasma levels. Journal of Vascular Research 29(3): 290-292
Lesher, G.A.; Beierschmitt, W.P. 1988: L-alpha-Acetylmethadol administration to lactating rat dams. Effect on hepatic aniline hydroxylase and ethylmorphine N-demethylase activities in rat pups. Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(1): 9-14
Taintor, Z.; Hough, G.; Plumb, M.; Murphy, B.F. 1975: L-alpha-acetylmethadol and methadone in Buffalo: safety and efficacy. American Journal of Drug and Alcohol Abuse 2(3-4): 317-330
Duerre, J.A.; Chakrabarty, S. 1975: L-amino acid oxidases of Proteus rettgeri. Journal of Bacteriology 121(2): 656-663
Leinweber, F.J.; Szpiech, J.M.; Di Carlo, F.J. 1978: L-bunolol metabolites in human urine. Pharmacology 16(2): 70-77
Sebban, C.; Tesolin, B.; Shvaloff, A.; Lemaitre-Guardiola, B. 1989: L-fenfluramine and haloperidol in rats: a qEEG comparison. Psychopharmacology 98(1): 131-138
File, S.E.; Guardiola-Lemaitre, B.J. 1988: L-fenfluramine in tests of dominance and anxiety in the rat. Neuropsychobiology 20(4): 205-211
Etienne, M.C.; Thyss, A.; Bertrand, Y.; Touraine, R.; Rubie, H.; Robert, A.; Milano, G. 1992: L-folinic acid versus d,l-folinic acid in rescue of high-dose methotrexate therapy in children. Journal of the National Cancer Institute 84(15): 1190-1195
Horský, J.; Stroufová, A.; Kozlová, J.; Divila, F.; Presl, J. 1975: LH-test in anovulations unsuccessfully treated by clomiphene. Ceskoslovenska Gynekologie 40(3): 180-183
Pfahl, M. 1976: Lac Repressor-operator interaction. Analysis of the X86 repressor mutant. Journal of Molecular Biology 106(3): 857-869
Mandecki, W.; Goldman, R.A.; Powell, B.S.; Caruthers, M.H. 1985: Lac Up-promoter mutants with increased homology to the consensus promoter sequence. Journal of Bacteriology 164(3): 1353-1355
Püttner, I.B.; Kaback, H.R. 1988: Lac permease of Escherichia coli containing a single histidine residue is fully functional. Proceedings of the National Academy of Sciences of the United States of America 85(5): 1467-1471
Menick, D.R.; Carrasco, N.; Antes, L.; Patel, L.; Kaback, H.R. 1987: Lac permease of Escherichia coli: arginine-302 as a component of the postulated proton relay. Biochemistry 26(21): 6638-6644
Carrasco, N.; Antes, L.M.; Poonian, M.S.; Kaback, H.R. 1986: Lac permease of Escherichia coli: histidine-322 and glutamic acid-325 may be components of a charge-relay system. Biochemistry 25(16): 4486-4488
Sellitti, M.A.; Pavco, P.A.; Steege, D.A. 1987: Lac repressor blocks in vivo transcription of lac control region DNA. Proceedings of the National Academy of Sciences of the United States of America 84(10): 3199-3203
Brown, M.; Figge, J.; Hansen, U.; Wright, C.; Jeang, K.T.; Khoury, G.; Livingston, D.M.; Roberts, T.M. 1987: Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49(5): 603-612
Kelsey, D.E.; Rounds, T.C.; York, S.S. 1979: Lac repressor changes conformation upon binding to poly[dA-T). Proceedings of the National Academy of Sciences of the United States of America 76(6): 2649-2653
Eismann, E.R.; Müller-Hill, B. 1990: Lac repressor forms stable loops in vitro with supercoiled wild-type lac DNA containing all three natural lac operators. Journal of Molecular Biology 213(4): 763-775
Lu, P.; Jarema, M.; Mosser, K.; Daniel, W.E. 1976: Lac repressor: 3-fluorotyrosine substitution for nuclear magnetic resonance studies. Proceedings of the National Academy of Sciences of the United States of America 73(10): 3471-3475
Plessis, A.; Robaglia, C.; Diolez, A.; Beyou, A.; Leach, F.; Casse-Delbart, F.; Richaud, F. 1985: LacZ gene fusions and insertion mutagenesis in the TL-region of Agrobacterium rhizogenes Ri plasmid. Plasmid 14(1): 17-27
Hofnung, M.; Jezierska, A.; Braun-Breton, C. 1976: LamB mutations in E. coli K12: growth of lambda host range mutants and effect of nonsense suppressors. Molecular and General Genetics: Mgg 145(2): 207-213
Jørgensen, P.; Mikkelsen, T. 1986: Lambda PJ4A, a lambda replacement vector carrying amber mutations for cloning of EcoRi fragments. Nucleic Acids Research 14(23): 9538
Zabarovsky, E.R.; Zagorskaya, E.G.; Kisselev, L.L. 1989: Lambda SK15--a diphasmid for construction expression cDNA libraries at BamHI and EcoRI sites with selection against non-recombinant and false recombinant phages. Nucleic Acids Research 17(11): 4408
Zabarovsky, E.R.; Turina, O.V.; Kisselev, L.L. 1989: Lambda SK9--a diphasmid for constructing genomic libraries, capable of converting inserts into plasmid and single stranded forms. Nucleic Acids Research 17(11): 4407
Baccichetti, F.; Bordin, F.; Carlassare, F. 1979: Lambda-Prophage induction by furocoumarin photosensitization. Experientia 35(2): 183-184
Yamamoto, N.; Wohlhieter, J.A.; Gemski, P.; Baron, L.S. 1978: Lambdaimm P22dis: a hybrid of coliphage lambda with both immunity regions of Salmonella phage P22. Molecular and General Genetics: Mgg 166(3): 233-243
Pourcel, C.; Tiollais, P. 1977: Lambdaplac5 derivatives, potential vectors for DNA fragments cleaved by Streptomyces stanfordii restriction enzyme (SstI). Gene 1(3-4): 281-286
Ohta, M.; Morita, T.; Shimotohno, K. 1990: Lck suppresses gene expression from various promoters including human T-cell leukemia virus type i promoter. Japanese Journal of Cancer Research: Gann 81(5): 440-444
Price, S.B.; Straley, S.C. 1989: LcrH, a gene necessary for virulence of Yersinia pestis and for the normal response of Y. pestis to ATP and calcium. Infection and Immunity 57(5): 1491-1498
Barve, S.S.; Straley, S.C. 1990: LcrR, a low-Ca2(+)-response locus with dual Ca2(+)-dependent functions in Yersinia pestis. Journal of Bacteriology 172(8): 4661-4671
Marc, B.; Lebon, E.; Mazeman, E. 1990: Leiomyoma of the bladder. Apropos of a case. Journal d'Urologie 96(1): 45-47
Gemmill, R.M.; Wessler, S.R.; Keller, E.B.; Calvo, J.M. 1979: Leu operon of Salmonella typhimurium is controlled by an attenuation mechanism. Proceedings of the National Academy of Sciences of the United States of America 76(10): 4941-4945
Aigner, T.G.; Ford, R.D.; Balster, R.L. 1978: Levo-Alpha-acetylmethadol and metabolites: some effects on schedule-controlled behavior in the rat. Pharmacology Biochemistry and Behavior 8(6): 735-737
Janssen, J.P.; Wagenaar, S.S.; van den Bosch, J.M.; Planteydt, H.T. 1990: Localized fibrous tumors of the pleura. Nederlands Tijdschrift Voor Geneeskunde 134(45): 2185-2189
Sasakawa, C.; Uno, Y.; Yoshikawa, M. 1987: Lon-sulA regulatory function affects the efficiency of transposition of Tn5 from lambda b221 cI857 Pam Oam to the chromosome. Biochemical and Biophysical Research Communications 142(3): 879-884
De Alborán, I.M.; Gutierrez, J.C.; Gonzalo, J.A.; Andreu, J.L.; Marcos, M.A.; Kroemer, G.; Martínez, C. 1992: Lpr T cells vaccinate against lupus in MRL/lpr mice. European Journal of Immunology 22(4): 1089-1093
Dagna Bricarelli, F.; Lamba Carbone, L.D.; Caffarena, G.; Cresta, E.; Frateschi, M.; Rasore-Quartino, A. 1979: Lq32qter trisomy due to maternal translocation t(1;6) (q32; q26). Pathologica 71(1013): 342
Holzhauer, C.; Kamp, G.A. 1991: Lung worm on a farm with summer barn feeding. Tijdschrift Voor Diergeneeskunde 116(2): 80-81
Mellentin, J.D.; Smith, S.D.; Cleary, M.L. 1989: Lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 58(1): 77-83
Tada, K. 1977: Lysine malabsorption syndrome. Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 1): 672-673
Rozencweig, M.; Von Hoff, D.D.; Cysyk, R.L.; Muggia, F.M. 1979: M-AMSA and PALA: two new agents in cancer chemotherapy. Cancer ChemoTherapy and Pharmacology 3(3): 135-141
Child, J.A.; Norfolk, D.R.; Franks, C.R.; Nys, G. 1987: M-AMSA and VP-16 combinations in the treatment of acute myeloid leukemia. British Journal of Haematology 65(2): 245
Keller, A.M.; Tsiatis, A.A.; Neiman, R.S.; Glick, J.H.; Mann, R.B. 1985: M-AMSA in refractory lymphoma. a phase Ii trial of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology 8(5): 449-452
Zittoun, R. 1985: M-AMSA: a review of clinical data. European Journal of Cancer and Clinical Oncology 21(6): 649-653
Gould, B.J.; Hall, P.M. 1987: M-Aminophenylboronate affinity ligands distinguish between nonenzymically glycosylated proteins and glycoproteins. Clinica Chimica Acta; International Journal of Clinical Chemistry 163(2): 225-230
Liang, R.; Chiu, E.; Chan, T.K.; Todd, D.; Ho, F. 1991: M-BACOD chemotherapy for intermediate- and high-grade non-Hodgkin's lymphoma. Cancer ChemoTherapy and Pharmacology 28(2): 135-138
Dana, B.W.; Dahlberg, S.; Miller, T.P.; Hartsock, R.J.; Balcerzak, S.; Coltman, C.A.; Carden, J.O.; Hartley, K.; Fisher, R.I. 1990: M-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase Ii trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 8(7): 1155-1162
Curzon, G.; Kennett, G.A. 1990: m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors. Trends in Pharmacological Sciences 11(5): 181-182
Kahn, R.S.; Wetzler, S. 1991: M-Chlorophenylpiperazine as a probe of serotonin function. Biological Psychiatry 30(11): 1139-1166
Griebel, G.; Misslin, R.; Pawlowski, M.; Vogel, E. 1991: M-Chlorophenylpiperazine enhances neophobic and anxious behaviour in mice. Neuroreport 2(10): 627-629
Ishihara, N.; Kanaya, A.; Ikeda, M. 1976: M-Dinitrobenzene intoxication due to skin absorption. International Archives of Occupational and Environmental Health 36(3): 161-168
Ring, M.; Armitage, I.M.; Huber, R.E. 1985: M-Fluorotyrosine substitution in beta-galactosidase; evidence for the existence of a catalytically active tyrosine. Biochemical and Biophysical Research Communications 131(2): 675-680
Gaucher, G.M. 1975: M-Hydroxybenzyl-alcohol dehydrogenase. Methods in Enzymology 43: 540-548
Suzuki, O.; Hattori, H.; Katsumata, Y.; Oya, M. 1979: m-Octopamine as a substrate for monoamine oxidase. Life Sciences 25(14): 1231-1235
Danielson, T.J.; Boulton, A.A.; Robertson, H.A. 1977: M-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs. Journal of Neurochemistry 29(6): 1131-1135
Ibrahim, K.E.; Couch, M.W.; Williams, C.M.; Fregly, M.J.; Midgley, J.M. 1985: M-Octopamine: normal occurrence with p-octopamine in mammalian sympathetic nerves. Journal of Neurochemistry 44(6): 1862-1867
Gachályi, B.; Káldor, A.; Szeberényi, S. 1978: M-Trifluoromethyl-alpha-ethylbenzhydrol: a new enzyme inducer. European Journal of Clinical Pharmacology 13(4): 299-302
Elovaara, E.; Zitting, A.; Nickels, J.; Aitio, A. 1987: M-Xylene inhalation destroys cytochrome P-450 in rat lung at low exposure. Archives of Toxicology 61(1): 21-26
Khawli, L.A.; Kassis, A.I. 1992: M-[125I]iodoaniline: a useful reagent for radiolabeling biotin. International Journal of Radiation Applications and Instrumentation. Part B Nuclear Medicine and Biology 19(3): 297-301
Juedes, M.J.; Kass, G.E.; Orrenius, S. 1992: M-iodobenzylguanidine increases the mitochondrial Ca2+ pool in isolated hepatocytes. Febs Letters 313(1): 39-42
Volterra, G.; Cutrufo, C.; Lecci, A. 1991: M-trifluoromethylphenylpiperazine and m-chlorophenylpiperazine-induced hypothermia in mice is reversed by tricyclic antidepressants and other drugs. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 1(4): 519-528
Faust, M.; Hastings, K.E.; Millward, S. 1975: M7G5'ppp5'GmptcpUp at the 5' terminus of reovirus messenger RNA. Nucleic Acids Research 2(8): 1329-1343
Shugart, L.; Chastain, B. 1979: M7guanosine in tRNA of Escherichia coli. International Journal of Biochemistry 10(2): 155-157
Vallé, A.; Garrone, P.; Yssel, H.; Bonnefoy, J.Y.; Freedman, A.S.; Freeman, G.; Nadler, L.M.; Banchereau, J. 1990: MAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1-transformed T cells. Immunology 69(4): 531-535
Giacomini, P.; Tecce, R.; Nicotra, M.R.; Cohen, B.B.; Mazzilli, M.C.; Natali, P.G. 1989: MAb KUL/05 identifies a denaturation-resistant determinant shared by class Ii MHC products DR, DQ and DP. Journal of Immunogenetics 16(3): 203-216
Robertson, D.W.; Bloomquist, W.; Wong, D.T.; Cohen, M.L. 1992: MCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors. Life Sciences 50(8): 599-605
Peters, J.; Takahashi, S.; Tada, M.; Miyake, Y. 1992: MGK-6-derived true tissue kallikrein is synthesized, processed, and targeted through a regulated secretory pathway in mouse pituitary AtT-20 cells. Journal of Biochemistry 111(5): 643-648
Pesce, C.M. 1985: Morphometric studies need review by statisticians. American Journal of Clinical Pathology 84(2): 258
Cotner, T.; Charbonneau, H.; Mellins, E.; Pious, D. 1989: MRNA abundance, rather than differences in subunit assembly, determine differential expression of HLA-DR beta 1 and -DR beta 3 molecules. Journal of Biological Chemistry 264(19): 11107-11111
Ovodov SYu; Alakhov YuB 1990: MRNA acetylated at 2'-OH-groups of ribose residues is functionally active in the cell-free translation system from wheat embryos. Febs Letters 270(1-2): 111-114
Ozasa, H.; Shindo, Y. 1985: MRNA activity of M-type lactate dehydrogenase in dermatofibrosarcoma protuberans. Journal of Dermatology 12(6): 502-505
Migliaccio, G.; Castagnola, P.; Leone, A.; Cerasuolo, A.; Bonatti, S. 1985: MRNA activity of a Sindbis virus defective-interfering RNA. Journal of Virology 55(3): 877-880
McFarlane-Anderson, N.; Bégin-Heick, N. 1991: MRNA and protein levels of the stimulatory guanine nucleotide regulatory protein Gs are lower in the testis of obese (ob/ob) mice. Cellular Signalling 3(3): 233-241
Arbuzov, V.A.; Krechetova, G.D.; Pigareva, M.I. 1979: MRNA breakdown in tumor cells in vivo under cycloheximide protein synthesis inhibition. Voprosy Meditsinskoi Khimii 25(6): 766-776
Shatkin, A.J. 1985: MRNA cap binding proteins: essential factors for initiating translation. Cell 40(2): 223-224
Altmann, M.; Handschin, C.; Trachsel, H. 1987: MRNA cap-binding protein: cloning of the gene encoding protein synthesis initiation factor eIF-4E from Saccharomyces cerevisiae. Molecular and Cellular Biology 7(3): 998-1003
Shatkin, A.J. 1987: MRNA caps--old and newer hats. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 7(6): 275-277
Farge, P.; Couble, P.; Magloire, H.; Dallaire, L. 1987: MRNA characterization of human fetal enamel matrix. Archives of Oral Biology 32(9): 655-658
Jirikowski, G.F.; Sanna, P.P.; Bloom, F.E. 1990: mRNA coding for oxytocin is present in axons of the hypothalamo-neurohypophysial tract. Proceedings of the National Academy of Sciences of the United States of America 87(19): 7400-7404
Balakin, A.G.; Bogdanova, S.L.; Skripkin, E.A. 1992: MRNA containing an extended Shine-Dalgarno sequence is translated independently of ribosomal protein S1. Biochemistry International 27(1): 117-129
Brawerman, G. 1989: MRNA decay: finding the right targets. Cell 57(1): 9-10
Arbusov, V.A. 1979: MRNA degradation in membrane-bound and free polyribosomes in rat liver cells after exposure to actinomycin D and cycloheximide. Voprosy Meditsinskoi Khimii 25(1): 62-67
Höfler, H.; Wolfe, H.J. 1989: MRNA detection by in situ hybridization with radioactive probes. Acta Histochemica. Supplementband 37: 79-82
Kim, R.; Hirabayashi, N.; Nishiyama, M.; Yorishima, T.; Toge, T.; Okada, K. 1991: MRNA expression of topoisomerase Ii in human tumors and normal tissues. Japanese Journal of Surgery 21(5): 587-589
Ciardiello, F.; Kim, N.; Liscia, D.S.; Bianco, C.; Lidereau, R.; Merlo, G.; Callahan, R.; Greiner, J.; Szpak, C.; Kidwell, W. 1989: MRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients. Journal of the National Cancer Institute 81(15): 1165-1171
Younes, M.A.; D'Agostino, J.; Besch, P.K. 1986: MRNA for insulin-like growth factor from human placenta. Alabama Journal of Medical Sciences 23(3): 285-289
Inouye, L.N.; Albini, A.; Chader, G.J.; Redmond, T.M.; Nickerson, J.M. 1989: MRNA for interphotoreceptor retinoid-binding protein (IRBP): distribution and size diversity in vertebrate species. Experimental Eye Research 49(2): 171-180
Fung, W.P.; Milland, J.; Schreiber, G. 1988: MRNA for kininogens and thiostatins (major acute phase alpha 1-proteins) in the liver of kininogen-deficient rats. Thrombosis Research 50(1): 113-120
Hofmann, S.L.; Russell, D.W.; Goldstein, J.L.; Brown, M.S. 1987: MRNA for low density lipoprotein receptor in brain and spinal cord of immature and mature rabbits. Proceedings of the National Academy of Sciences of the United States of America 84(17): 6312-6316
Goriunova, L.E.; Barshevskaia, T.N.; Shevelev, A.Ia.; Belogurov, A.A.; Bibilashvili, R.Sh. 1988: MRNA for the plasminogen activator of the urokinase type: translation in oocytes of Xenopus laevis. Molekuliarnaia Biologiia 22(2): 549-555
Ikuta, T.; Yoshida, A. 1986: MRNA for the three human alcohol dehydrogenase subunits: size heterogeneity and developmental changes. Biochemical and Biophysical Research Communications 140(3): 1020-1027
Baird, J.; Lazarus, G.S.; Belin, D.; Vassalli, J.D.; Busso, N.; Gubler, P.; Jensen, P.J. 1990: MRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. Journal of Investigative Dermatology 95(5): 548-552
Sakharova, N.K.; Grechko, V.V.; Goriunova, L.E. 1976: MRNA fractions of mouse plasmacytoma cells. Molekuliarnaia Biologiia 10(1): 122-131
Lerma, J.; Kushner, L.; Spray, D.C.; Bennett, M.V.; Zukin, R.S. 1989: MRNA from NCB-20 cells encodes the N-methyl-D-aspartate/phencyclidine receptor: a Xenopus oocyte expression study. Proceedings of the National Academy of Sciences of the United States of America 86(5): 1708-1711
Moshier, J.A.; Luk, G.D.; Huang, R.C. 1986: MRNA from human colon tumor and mucosa related to the pol gene of an endogenous A-type retrovirus. Biochemical and Biophysical Research Communications 139(3): 1071-1077
Chinnadurai, G.; Rho, H.M.; Horton, R.B.; Green, M. 1976: MRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. Journal of Virology 20(1): 255-263
Martin, S.A.; Moss, B. 1976: MRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites. Journal of Biological Chemistry 251(23): 7313-7321
Sutcliffe, J.G. 1988: MRNA in the mammalian central nervous system. Annual Review of Neuroscience 11: 157-198
Slagboom, P.E.; de Leeuw, W.J.; Vijg, J. 1990: MRNA levels and methylation patterns of the tyrosine aminotransferase gene in aging inbred rats. Febs Letters 269(1): 128-130
Hazlewood, J.; Fonagy, A.; Henning, D.; Freeman, J.W.; Busch, R.K.; Busch, H. 1989: MRNA levels for human nucleolar protein P120 in tumor and nontumor cells. Cancer Communications 1(1): 29-34
Goldstein, M.E.; Weiss, S.R.; Lazzarini, R.A.; Shneidman, P.S.; Lees, J.F.; Schlaepfer, W.W. 1988: MRNA levels of all three neurofilament proteins decline following nerve transection. Brain Research 427(3): 287-291
Kitamura, K.; Mizuno, Y.; Hatayama, I.; Sato, K.; Tamura, S.; Nagao, M.; Tsuiki, S.; Kikuchi, K. 1992: MRNA levels of catalytic subunits of protein phosphatases 1, 2A, and 2C in hepatocarcinogenesis. Japanese Journal of Cancer Research: Gann 83(1): 66-71
Colella, R.; Roisen, F.J.; Bird, J.W. 1986: MRNA levels of cathepsins B and D during myogenesis. Biomedica Biochimica Acta 45(11-12): 1413-1419
Sulimova, G.E.; Akhundova, A.A.; Kapelinskaia, T.V.; Gorodetskiĭ, S.I. 1985: MRNA localization and content in bovine kininogen. Biokhimiia 50(2): 279-288
Muthukrishnan, S.; Filipowicz, W.; Sierra, J.M.; Both, G.W.; Shatkin, A.J.; Ochoa, S. 1975: MRNA methylation and protein synthesis in extracts from embryos of brine shrimp, Artemia salina. Journal of Biological Chemistry 250(24): 9336-9341
Noonan, K.E.; Roninson, I.B. 1988: MRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Research 16(21): 10366
Rappolee, D.A.; Werb, Z. 1990: MRNA phenotyping for studying gene expression in small numbers of cells: platelet-derived growth factor and other growth factors in wound-derived macrophages. American Journal of Respiratory Cell and Molecular Biology 2(1): 3-10
Munroe, D.; Jacobson, A. 1990: MRNA poly(A) tail, a 3' enhancer of translational initiation. Molecular and Cellular Biology 10(7): 3441-3455
Adam, S.A.; Nakagawa, T.; Swanson, M.S.; Woodruff, T.K.; Dreyfuss, G. 1986: MRNA polyadenylate-binding protein: gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence. Molecular and Cellular Biology 6(8): 2932-2943
Van Santen, V.L.; Spritz, R.A. 1985: MRNA precursor splicing in vivo: sequence requirements determined by deletion analysis of an intervening sequence. Proceedings of the National Academy of Sciences of the United States of America 82(9): 2885-2889
Pape, M.E.; Melchior, G.W.; Marotti, K.R. 1991: MRNA quantitation by a simple and sensitive RNAse protection assay. Genetic Analysis Techniques and Applications 8(7): 206-213
Elango, N.; Kövamees, J.; Varsanyi, T.M.; Norrby, E. 1989: MRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene. Journal of Virology 63(3): 1413-1415
Elango, N.; Satake, M.; Venkatesan, S. 1985: MRNA sequence of three respiratory syncytial virus genes encoding two nonstructural proteins and a 22K structural protein. Journal of Virology 55(1): 101-110
Valiquette, G.; Zimmerman, E.A.; Roberts, J.L. 1985: MRNA sequence predictions from homologous protein sequences. Journal of Theoretical Biology 112(3): 445-458
Kramerov, D.A.; Ryskov, A.P. 1979: MRNA sequences complementary to the double-stranded regions of pre-mRNA. Hybridization experiments using RNA mercuriation and chromatography on sulfhydryl-Sepharose. Molekuliarnaia Biologiia 13(3): 601-612
Pikielny, C.W.; Rosbash, M. 1985: MRNA splicing efficiency in yeast and the contribution of nonconserved sequences. Cell 41(1): 119-126
Peltz, S.W.; Jacobson, A. 1992: MRNA stability: in trans-it. Current Opinion in Cell Biology 4(6): 979-983
Hayashi, M.N.; Yaghmai, R.; McConnell, M.; Hayashi, M. 1989: MRNA stabilizing signals encoded in the genome of the bacteriophage phi x174. Molecular and General Genetics: Mgg 216(2-3): 364-371
Darnell, F.E. 1976: MRNA structure and function. Progress in Nucleic Acid Research and Molecular Biology 19: 493-511
Baim, S.B.; Sherman, F. 1988: MRNA structures influencing translation in the yeast Saccharomyces cerevisiae. Molecular and Cellular Biology 8(4): 1591-1601
Watson, G.; Paigen, K. 1988: MRNA synthesis rates in vivo for androgen-inducible sequences in mouse kidney. Molecular and Cellular Biology 8(5): 2117-2124
Gonzalez-Brito, A.; Troiani, M.E.; Menendez-Pelaez, A.; Delgado, M.J.; Reiter, R.J. 1990: MRNA transcription determines the lag period for the induction of pineal melatonin synthesis in the Syrian hamster pineal gland. Journal of Cellular Biochemistry 44(1): 55-60
Jerome, J.F.; Jaehning, J.A. 1986: MRNA transcription in nuclei isolated from Saccharomyces cerevisiae. Molecular and Cellular Biology 6(5): 1633-1639
Neale, G.A.; Kitchingman, G.R. 1991: MRNA transcripts initiating within the human immunoglobulin mu heavy chain enhancer region contain a non-translatable exon and are extremely heterogeneous at the 5' end. Nucleic Acids Research 19(9): 2427-2433
Dean, C.; Tamaki, S.; Dunsmuir, P.; Favreau, M.; Katayama, C.; Dooner, H.; Bedbrook, J. 1986: MRNA transcripts of several plant genes are polyadenylated at multiple sites in vivo. Nucleic Acids Research 14(5): 2229-2240
Robertson, M.W.; Mehl, V.S.; Richards, M.L.; Liu, F.T. 1991: MRNA variants encoding multiple forms of the high-affinity IgE receptor alpha subunit in transformed and nontransformed mast cells. International Archives of Allergy and Applied Immunology 96(4): 289-295
Barbosa, E.; Moss, B. 1978: MRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Characteristics and substrate specificity. Journal of Biological Chemistry 253(21): 7698-7702
Barbosa, E.; Moss, B. 1978: MRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Purification and physical properties. Journal of Biological Chemistry 253(21): 7692-7697
Babkina, G.T.; Vladimirov, S.N.; Dryga, S.A.; Zenkova, M.A.; Karpova, G.G. 1988: MRNA-binding site of ribosomes at different stages of translation. II. Affinity modification of Escherichia coli ribosomes bya benzylidene derivative of AUGU6 in pre- and post-translation complexes. Molekuliarnaia Biologiia 22(2): 357-361
Stevens, A. 1988: MRNA-decapping enzyme from Saccharomyces cerevisiae: purification and unique specificity for long RNA chains. Molecular and Cellular Biology 8(5): 2005-2010
Chu, F.; Caldwell, P.; Weissbach, H.; Brot, N. 1977: MRNA-dependent in vitro synthesis of ribosomal proteins L12 and L10 and elongation factor Tu. Proceedings of the National Academy of Sciences of the United States of America 74(12): 5387-5391
Bielinska, M.; Boime, I. 1978: MRNA-dependent synthesis of a glycosylated subunit of human chorionic gonadotropin in cell-free extracts derived from ascites tumor cells. Proceedings of the National Academy of Sciences of the United States of America 75(4): 1768-1772
Szczesna, E.; Boime, I. 1976: MRNA-dependent synthesis of authentic precursor to human placental lactogen: conversion to its mature hormone form in ascites cell-free extracts. Proceedings of the National Academy of Sciences of the United States of America 73(4): 1179-1183
Tuite, M.F.; Plesset, J. 1986: MRNA-dependent yeast cell-free translation systems: theory and practice. Yeast 2(1): 35-52
Kourides, I.A.; Weintraub, B.D. 1979: MRNA-directed biosynthesis of alpha subunit of thyrotropin: translation in cell-free and whole-cell systems. Proceedings of the National Academy of Sciences of the United States of America 76(1): 298-302
Smart, T.G.; Houamed, K.M.; Van Renterghem, C.; Constanti, A. 1987: MRNA-directed synthesis and insertion of functional amino acid receptors in Xenopus laevis oocytes. Biochemical Society Transactions 15(1): 117-122
Barrieux, A.; Rosenfeld, M.G. 1978: MRNA-induced dissociation of initiation factor 2. Journal of Biological Chemistry 253(18): 6311-6314
Kühn, L.C. 1991: MRNA-protein interactions regulate critical pathways in cellular iron metabolism. British Journal of Haematology 79(1): 1-5
Tani, T.; Ohshima, Y. 1991: MRNA-type introns in U6 small nuclear RNA genes: implications for the catalysis in pre-mRNA splicing. Genes and Development 5(6): 1022-1031
Bowes, C.; Farber, D.B. 1987: MRNAs coding for proteins of the cGMP cascade in the degenerative retina of the rd mouse. Experimental Eye Research 45(4): 467-480
Nemer, M.; Surrey, S. 1976: MRNAs containing and lacking poly (A) function as separate and distinct classes during embryonic development. Progress in Nucleic Acid Research and Molecular Biology 19: 119-122
Azen, E.A.; Hellekant, G.; Sabatini, L.M.; Warner, T.F. 1990: MRNAs for PRPs, statherin, and histatins in von Ebner's gland tissues. Journal of Dental Research 69(11): 1724-1730
Shea, D.K.; Walsh, C.J. 1987: MRNAs for alpha- and beta-tubulin and flagellar calmodulin are among those coordinately regulated when Naegleria gruberi amebae differentiate into flagellates. Journal of Cell Biology 105(3): 1303-1309
Yeh, J.; Danehy, F.T.; Osathanondh, R.; Villa-Komaroff, L. 1991: MRNAs for insulin-like growth factor-Ii (IGF-II) and variant IGF-Ii are co-expressed in human fetal ovary and uterus. Molecular and Cellular Endocrinology 80(1-3): 75-82
Egly, J.M.; Elkaim, R.; Pierre, M. 1979: MRNP proteins, initiation factors and phosphorylation. Molecular Biology Reports 5(1-2): 91-97
Deschamps, S.; Viel, A.; Garrigos, M.; Denis, H.; le Maire, M. 1992: MRNP4, a major mRNA-binding protein from Xenopus oocytes is identical to transcription factor FRG Y2. Journal of Biological Chemistry 267(20): 13799-13802
Roman, C.; Matera, A.G.; Cooper, C.; Artandi, S.; Blain, S.; Ward, D.C.; Calame, K. 1992: MTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Molecular and Cellular Biology 12(2): 817-827
Ivashkiv, L.B.; Liou, H.C.; Kara, C.J.; Lamph, W.W.; Verma, I.M.; Glimcher, L.H. 1990: MXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Molecular and Cellular Biology 10(4): 1609-1621
Shen, M.M.; Hodgkin, J. 1988: Mab-3, a gene required for sex-specific yolk protein expression and a male-specific lineage in C. elegans. Cell 54(7): 1019-1031
Marchal, C.; Greenblatt, J.; Hofnung, M. 1978: MalB region in Escherichia coli K-12: specialized transducing bacteriophages and first restriction map. Journal of Bacteriology 136(3): 1109-1119
Gilson, E.; Rousset, J.P.; Charbit, A.; Perrin, D.; Hofnung, M. 1986: MalM, a new gene of the maltose regulon in Escherichia coli K12. I. malM is the last gene of the malK-lamB operon and encodes a periplasmic protein. Journal of Molecular Biology 191(3): 303-311
Rousset, J.P.; Gilson, E.; Hofnung, M. 1986: MalM, a new gene of the maltose regulon in Escherichia coli K12. II. Mutations affecting the signal peptide of the MalM protein. Journal of Molecular Biology 191(3): 313-320
Ellis, F.R.; Clarke, I.M.; Appleyard, T.N.; Dinsdale, R.C. 1975: Malignant hyperpyrexia induced by nitrous oxide successfully treated by steroids. British Journal of Anaesthesia 47(5): 632
Lesbordes, J.L.; Coulaud, B.; Georges, A.J. 1990: Malnutrition and human immunodeficiency virus (HIV) in Bagui (Central Africa). Study and 2-year follow-up of a cohort of 175 malnourished children and 101 mothers. Medecine Tropicale: Revue du Corps de Sante Colonial 50(2): 161-165
Thomas, H. 1975: Management of late stage carcinoma of the bladder. British Journal of Urology 47(2): 233
Divaris, M.; Goudot, P.; Princ, G.; Lalo, J.; Vaillant, J.M. 1992: Mandibular reconstruction by free bone flaps with micro-anastomosis. our current indications. Annales de Chirurgie Plastique et Esthetique 37(3): 297-308
Cohen, S.P.; McMurry, L.M.; Levy, S.B. 1988: MarA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. Journal of Bacteriology 170(12): 5416-5422
Hächler, H.; Cohen, S.P.; Levy, S.B. 1991: MarA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology 173(17): 5532-5538
Berberich, S.; Hyde-DeRuyscher, N.; Espenshade, P.; Cole, M. 1992: Max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors. Oncogene 7(4): 775-779
Drummond, G.B.; Gordon, N.H. 1975: Maximum expiratory flow-volume relationships after upper abdominal surgery. British Journal of Anaesthesia 47(5): 637
Michieli, M.; Giacca, M.; Fanin, R.; Damiani, D.; Geromin, A.; Baccarani, M. 1991: mdr-1 gene amplification in acute lymphoblastic leukaemia prior to antileukaemic treatment. British Journal of Haematology 78(2): 288-289
Gekeler, V.; Weger, S.; Probst, H. 1990: Mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles. Biochemical and Biophysical Research Communications 169(2): 796-802
Buschman, E.; Arceci, R.J.; Croop, J.M.; Che, M.; Arias, I.M.; Housman, D.E.; Gros, P. 1992: Mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. Journal of Biological Chemistry 267(25): 18093-18099
Way, J.C.; Chalfie, M. 1988: Mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell 54(1): 5-16
Savage, C.; Hamelin, M.; Culotti, J.G.; Coulson, A.; Albertson, D.G.; Chalfie, M. 1989: Mec-7 is a beta-tubulin gene required for the production of 15-protofilament microtubules in Caenorhabditis elegans. Genes and Development 3(6): 870-881
Gandola, C. 1991: MedTrendo: an interactive medical newsletter created with hypermedia. Proceedings. Symposium on Computer Applications in Medical Care 1991: 882
Roncoroni, A.J.; Simonetti, D.; Morck, E. 1985: Medical treatment of a cerebral tuberculoma. Medicina 45(3): 287-290
Schroeder, A.L.; Raju, N.B. 1991: Mei-2, a mutagen-sensitive mutant of Neurospora defective in chromosome pairing and meiotic recombination. Molecular and General Genetics: Mgg 231(1): 41-48
Joachim, M.; Collignon, J.; Rumeau, C. 1979: Meningioma of the base of the skull with orbital extension and the diagnostic role of tomodensitometry. Bulletin de la Societe Belge d'Ophtalmologie 184: 41-51
Van Alphen, L.; Lugtenberg, B.; van Boxtel, R.; Hack, A.M.; Verhoef, C.; Havekes, L. 1979: MeoA is the structural gene for outer membrane protein c of Escherichia coli K12. Molecular and General Genetics: Mgg 169(2): 147-155
Domingo, J.L.; Bosque, M.A.; Piera, V. 1991: Meso-2,3-Dimercaptosuccinic acid and prevention of arsenite embryotoxicity and teratogenicity in the mouse. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 17(2): 314-320
Aposhian, H.V.; Aposhian, M.M. 1990: Meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annual Review of Pharmacology and Toxicology 30: 279-306
Tessel, R.E.; Woods, J.H. 1978: Meta Substituted N-ethylamphetamine self injection responding in the rhesus monkey: structure-activity relationships. Journal of Pharmacology and Experimental Therapeutics 205(2): 274-281
Lewin, A.H.; de Costa, B.R.; Rice, K.C.; Skolnick, P. 1989: Meta- and para-isothiocyanato-t-butylbicycloorthobenzoate: irreversible ligands of the gamma-aminobutyric acid-regulated chloride ionophore. Molecular Pharmacology 35(2): 189-194
Anonymous 1991: Methods for gene transfer. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(13): 2226-2250
Coyer, J.; Andersen, J.; Forst, S.A.; Inouye, M.; Delihas, N. 1990: MicF RNA in ompB mutants of Escherichia coli: different pathways regulate micF RNA levels in response to osmolarity and temperature change. Journal of Bacteriology 172(8): 4143-4150
Bushman, J.A.; Al-Abrak, M.H.; Askill, S. 1975: Mine rescue techniques applied to closed circuit anaesthesia. British Journal of Anaesthesia 47(5): 633
Buckles, G.R.; Smith, Z.D.; Katz, F.N. 1992: Mip causes hyperinnervation of a retinotopic map in Drosophila by excessive recruitment of R7 photoreceptor cells. Neuron 8(6): 1015-1029
Richmond, D.R.; Halliday, E.J. 1979: Mm vs mV. Circulation 59(6): 1337
Martin, J.L.; Rose, K.; Hughes, G.J.; Magistretti, P.J. 1986: Mono[125I]iodo-Tyr10,MetO17]-vasoactive intestinal polypeptide. Preparation, characterization, and use for radioimmunoassay and receptor binding. Journal of Biological Chemistry 261(12): 5320-5327
Vande Woude, G.F.; Buccione, R.; Daar, I.; Eppig, J.J.; Oskarsson, M.; Paules, R.; Sagata, N.; Yew, N. 1990: Mos proto-oncogene function. Ciba Foundation Symposium 150: 147-160; Discussion: 160-162
Touray, M.; Ryan, F.; Saurer, S.; Martin, F.; Jaggi, R. 1991: Mos-induced inhibition of glucocorticoid receptor function is mediated by Fos. Oncogene 6(2): 211-217
Díaz, I.; Ehrenberg, M. 1991: Ms2i6A deficiency enhances proofreading in translation. Journal of Molecular Biology 222(4): 1161-1171
Lampson, B.C.; Inouye, S.; Inouye, M. 1991: MsDNA of bacteria. Progress in Nucleic Acid Research and Molecular Biology 40: 1-24
Johns, D.R. 1990: MtDNA deletions in Kearns-Sayre. Neurology 40(8): 1322-1323
Evans, R.G.; Olley, J.E.; Rice, G.E.; Abrahams, J.M. 1989: Mu- and K-opiate receptor agonists reduce plasma neurohypophysial hormone concentrations in water-deprived and normally hydrated rats. Clinical and Experimental Pharmacology and Physiology 16(3): 191-197
Marson, L.; Kiritsy-Roy, J.A.; Van Loon, G.R. 1989: Mu-Opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress. American Journal of Physiology 257(4 Part 2): R901-R908
Van Vliet, B.J.; De Vries, T.J.; Wardeh, G.; Mulder, A.H.; Schoffelmeer, A.N. 1991: Mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure. European Journal of Pharmacology 208(2): 105-111
Polastron, J.; Boyer, M.J.; Quertermont, Y.; Thouvenot, J.P.; Meunier, J.C.; Jauzac, P. 1990: Mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellum. Journal of Neurochemistry 54(2): 562-570
Hassen, A.H.; Feuerstein, G. 1987: Mu-Opioid receptors in NTS elicit pressor responses via sympathetic pathways. American Journal of Physiology 252(1 Pt 2): H156-H162
Jonsson, V.; Videbek, A.; Axelsen, N.H.; Harboe, M. 1976: Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects. Scandinavian Journal of Haematology 16(3): 209-217
Cruz, L.J.; Kupryszewski, G.; LeCheminant, G.W.; Gray, W.R.; Olivera, B.M.; Rivier, J. 1989: Mu-conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling, and receptor characterization. Biochemistry 28(8): 3437-3442
Kim, R.Y.; Gasser, R.; Wistow, G.J. 1992: Mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proceedings of the National Academy of Sciences of the United States of America 89(19): 9292-9296
Ukomadu, C.; Zhou, J.; Sigworth, F.J.; Agnew, W.S. 1992: Mui Na+ channels expressed transiently in human embryonic kidney cells: biochemical and biophysical properties. Neuron 8(4): 663-676
Dai, D.; Ishiguro, E.E. 1988: MurH, a new genetic locus in Escherichia coli involved in cell wall peptidoglycan biosynthesis. Journal of Bacteriology 170(5): 2197-2201
Siegel, E.C.; Ivers, J.J. 1975: Mut-25, a mutation to mutator linked to purA in Escherichia coli. Journal of Bacteriology 121(2): 524-530
Michaels, M.L.; Cruz, C.; Miller, J.H. 1990: MutA and mutC: two mutator loci in Escherichia coli that stimulate transversions. Proceedings of the National Academy of Sciences of the United States of America 87(23): 9211-9215
Cabrera, M.; Nghiem, Y.; Miller, J.H. 1988: MutM, a second mutator locus in Escherichia coli that generates G.C----T.A transversions. Journal of Bacteriology 170(11): 5405-5407
Andrews, G.P.; Maurelli, A.T. 1992: MxiA of Shigella flexneri 2a, which facilitates export of invasion plasmid antigens, encodes a homolog of the low-calcium-response protein, LcrD, of Yersinia pestis. Infection and Immunity 60(8): 3287-3295
Martinerie, C.; Soret, J.; Perbal, B. 1987: Myb-specific probes. Nucleic Acids Research 15(3): 1329-1330
Fauquet, M.; Stehelin, D.; Saule, S. 1990: Myc products induce the expression of catecholaminergic traits in quail neural crest-derived cells. Proceedings of the National Academy of Sciences of the United States of America 87(4): 1546-1550
Västrik, I.; Mäkelä, T.P.; Koskinen, P.J.; Saksela, K.; Alitalo, K. 1991: Myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer. Princess Takamatsu Symposia 22: 307-318
Davis, C.E.; Colmerauer, M.E.; Kim, C.H.; Matthews, B.; Guiney, D.G. 1989: Myc-related proteins and DNA sequences in Trypanosoma brucei. Microbial Pathogenesis 7(1): 45-53
Takaku, F. 1985: Myelodysplastic syndrome. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 74(9): 1223-1226
Delfert, D.M.; Hill, S.; Pershadsingh, H.A.; Sherman, W.R.; McDonald, J.M. 1986: Myo-Inositol 1,4,5-trisphosphate mobilizes Ca2+ from isolated adipocyte endoplasmic reticulum but not from plasma membranes. Biochemical Journal 236(1): 37-44
Takenawa, T.; Wada, E.; Tsumita, T. 1977: Myo-Inositol binding and transport in brush border membranes of rat kidney. Biochimica et Biophysica Acta 464(1): 108-117
Burton, L.E.; Wells, W.W. 1976: Myo-Inositol metabolism during lactation and development in the rat. The prevention of lactation-induced fatty liver by dietary myo-inositol. Journal of Nutrition 106(11): 1617-1628
Yorek, M.A.; Dunlap, J.A.; Ginsberg, B.H. 1987: Myo-Inositol metabolism in 41A3 neuroblastoma cells: effects of high glucose and sorbitol levels. Journal of Neurochemistry 48(1): 53-61
Burton, L.E.; Ray, R.E.; Bradford, J.R.; Orr, J.P.; Nickerson, J.A.; Wells, W.W. 1976: Myo-Inositol metabolism in the neonatal and developing rat fed a myo-inositol-free diet. Journal of Nutrition 106(11): 1610-1616
Koller, F.; Hoffmann-Ostenhof, O. 1979: Myo-Inositol oxygenase from rat kidneys. I: Purification by affinity chromatography; physical and catalytic properties. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 360(4): 507-513
Hamblin, M.R.; Flora, J.S.; Potter, B.V. 1987: Myo-Inositol phosphorothioates, phosphatase-resistant analogues of myo-inositol phosphates. Synthesis of DL-myo-inositol 1,4-bisphosphate and DL-myo-inositol 1,4-bisphosphorothioate. Biochemical Journal 246(3): 771-774
Mustelin, T.; Pösö, H.; Iivanainen, A.; Andersson, L.C. 1986: Myo-Inositol reverses Li+-induced inhibition of phosphoinositide turnover and ornithine decarboxylase induction during early lymphocyte activation. European Journal of Immunology 16(7): 859-861
Cooke, A.M.; Nahorski, S.R.; Potter, B.V. 1989: Myo-inositol 1,4,5-trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5-phosphatase. Febs Letters 242(2): 373-377
Downes, C.P.; Macphee, C.H. 1990: Myo-inositol metabolites as cellular signals. European Journal of Biochemistry 193(1): 1-18
Koller, F.; Koller, E. 1990: Myo-inositol oxygenase from rat kidneys. Substrate-dependent oligomerization. European Journal of Biochemistry 193(2): 421-427
Stephens, L.R.; Hawkins, P.T.; Stanley, A.F.; Moore, T.; Poyner, D.R.; Morris, P.J.; Hanley, M.R.; Kay, R.R.; Irvine, R.F. 1991: Myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochemical Journal 275: 485-499
Wiesinger, H. 1991: Myo-inositol transport in mouse astroglia-rich primary cultures. Journal of Neurochemistry 56(5): 1698-1704
Scalera, V.; Natuzzi, D.; Prezioso, G. 1991: Myo-inositol transport in rat intestinal brush border membrane vesicles, and its inhibition by D-glucose. Biochimica et Biophysica Acta 1062(2): 187-192
Thurston, J.H.; Sherman, W.R.; Hauhart, R.E.; Kloepper, R.F. 1989: Myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatric Research 26(5): 482-485
Asano, K. 1977: Myxomatous transformation of cardiac valves: non-rheumatic valvular diseases and their surgical treatment. Japanese Circulation Journal 41(2): 185-188
Watson, W.A.; Broan, J.M. 1975: Salmonella infection and meat hygiene: poultry meat. Veterinary Record 96(16): 351-353
Ljung, B.; Hallgren, P. 1975: N the mechanism of inhibitory action of vibrations as studied in a molluscan catch muscle and in vertebrate vascular smooth muscle. Acta Physiologica Scandinavica 95(4): 424-430
Cunnane, S.C.; McAdoo, K.R.; Horrobin, D.F. 1986: N-3 Essential fatty acids decrease weight gain in genetically obese mice. British Journal of Nutrition 56(1): 87-95
Innis, S.M. 1992: N-3 fatty acid requirements of the newborn. Lipids 27(11): 879-885
Ernst, E.; Saradeth, T.; Achhammer, G. 1991: N-3 fatty acids and acute-phase proteins. European Journal of Clinical Investigation 21(1): 77-82
Dyerberg, J.; Schmidt, E.B. 1989: N-3 fatty acids and cardiovascular disease--observations generated by studies in Greenland Eskimos. Wiener Klinische Wochenschrift 101(8): 277-282
Lands, W.E.; Pendleton, R.B. 1988: N-3 fatty acids and hydroperoxide activation of fatty acid oxygenases. Basic Life Sciences 49: 675-681
Schmidt, E.B.; Pedersen, J.O.; Varming, K.; Ernst, E.; Jersild, C.; Grunnet, N.; Dyerberg, J. 1991: N-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 11(2): 429-435
Seidelin, K.N.; Myrup, B.; Fischer-Hansen, B. 1992: N-3 fatty acids in adipose tissue and coronary artery disease are inversely related. American Journal of Clinical Nutrition 55(6): 1117-1119
Simopoulos, A.P.; Salem, N. 1989: N-3 fatty acids in eggs from range-fed Greek chickens. New England Journal of Medicine 321(20): 1412
Nordøy, A.; Dyerberg, J. 1989: N-3 fatty acids in health and disease. Introduction. Journal of internal medicine. Supplement 731: 1-3
Bjerve, K.S.; Fougner, K.J.; Midthjell, K.; Bønaa, K. 1989: N-3 fatty acids in old age. Journal of Internal Medicine. Suppl 731: 191-196
Force, T.; Malis, C.D.; Guerrero, J.L.; Varadarajan, G.S.; Bonventre, J.V.; Weber, P.C.; Leaf, A. 1989: N-3 fatty acids increase postischemic blood flow but do not reduce myocardial necrosis. American Journal of Physiology 257(4 Part 2): H1204-H1210
Wolfram, G. 1990: n-3 fatty acids--health aspects. Bibliotheca Nutritio et Dieta 1990(46): 110-119
Karmali, R. 1992: N-3 fatty acids: biochemical actions in cancer. Journal of Nutritional Science and Vitaminology Spec No: 148-152
Schmidt, E.B.; Varming, K.; Svaneborg, N.; Dyerberg, J. 1992: N-3 polyunsaturated fatty acid supplementation (Pikasol) in men with moderate and severe hypertriglyceridaemia: a dose-response study. Annals of Nutrition and Metabolism 36(5-6): 283-287
Dyerberg, J. 1988: N-3 polyunsaturated fatty acids and their possible role in the prevention of diseases. Nordisk Medicin 103(5): 161-5 188
Anonymous 1989: N-3 polyunsaturated fatty acids, interleukin-1, and tumor necrosis factor. New England Journal of Medicine 321(1): 55-56
Crawford, M.A.; Doyle, W.; Drury, P.; Lennon, A.; Costeloe, K.; Leighfield, M. 1989: N-6 and n-3 fatty acids during early human development. Journal of Internal Medicine. Suppl 731: 159-169
Vorob'eva, L.I.; Kraeva, N.I.; Ebringer, L.; Ol'sinskaia, N.L. 1979: N-Alkane oxidation by propionic acid bacteria. Mikrobiologiia 48(1): 33-38
Forman, S.A.; Verkman, A.S.; Dix, J.A.; Solomon, A.K. 1985: N-Alkanols and halothane inhibit red cell anion transport and increase band 3 conformational change rate. Biochemistry 24(18): 4859-4866
Oxford, G.S.; Swenson, R.P. 1979: N-Alkanols potentiate sodium channel inactivation in squid giant axons. Biophysical Journal 26(3): 585-590
Poulter, L.; Karrer, R.; Burlingame, A.L. 1991: N-Alkyl p-aminobenzoates as derivatizing agents in the isolation, separation, and characterization of submicrogram quantities of oligosaccharides by liquid secondary ion mass spectrometry. Analytical Biochemistry 195(1): 1-13
Tramposch, W.G.; Weber, S.G. 1986: N-Alkyldimethylammonium propanesulfonates as stationary phase modifiers in reversed-phase liquid chromatography. Analytical Chemistry 58(14): 3006-3010
Gubala, W. 1990: N-Butanol in blood as the indicator of how long a dead body lay in water. Forensic Science International 46(1-2): 127-128
Jönsson, A.K.; Steen, G. 1978: N-Butoxyacetic acid, a urinary metabolite from inhaled n-butoxyethanol (Butylcellosolve). Acta Pharmacologica et Toxicologica 42(5): 354-356
Brothers, M.F.; Kaufmann, J.C.; Fox, A.J.; Deveikis, J.P. 1989: N-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Ajnr. American Journal of Neuroradiology 10(4): 777-786
Anonymous 1986: N-Butyl acrylate. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 39: 67-79
Eadsforth, C.V.; Logan, C.J.; Page, J.A.; Regan, P.D. 1985: N-Butylglycidyl ether: the formation of a novel metabolite of an epoxide. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(2): 263-264
Smith, P.J. 1986: N-Butyrate alters chromatin accessibility to DNA repair enzymes. Carcinogenesis 7(3): 423-429
Bahn, R.S.; Zeller, J.C.; Smith, T.J. 1988: N-Butyrate increases c-erb a oncogene expression in human colon fibroblasts. Biochemical and Biophysical Research Communications 150(1): 259-262
Mitsuhashi, T.; Uchimura, H.; Takaku, F. 1987: N-Butyrate increases the level of thyroid hormone nuclear receptor in non-pituitary cultured cells. Journal of Biological Chemistry 262(9): 3993-3999
Smith, T.J. 1987: N-Butyrate inhibition of hyaluronate synthesis in cultured human fibroblasts. Journal of Clinical Investigation 79(5): 1493-1497
Lim, L. 1992: N-Chimaerin and neuronal signal transduction mechanisms. Biochemical Society Transactions 20(3): 611-614
Mogilevich, N.F.; Tashirev, A.B.; Romanova, E.A. 1987: N-Chloroaniline transformation by Escherichia coli under anaerobic conditions. Mikrobiologiia 56(2): 205-208
Karikó, K.; Ludwig, J. 1985: N-Decyl-NHpppA2'p5'A2'p5'A A phosphatase-resistant, active pppA2'p5'A2'p5'A analog. Biochemical and Biophysical Research Communications 128(2): 695-698
Anonymous 1988: N-Hexane. Reviews of Environmental Contamination and Toxicology 106: 155-164
Ikeda, M.; Kasahara, M. 1986: N-Hexane and benzene contents in gasoline for industrial purpose. Industrial Health 24(1): 63-66
DeCaprio, A.P. 1987: N-Hexane neurotoxicity: a mechanism involving pyrrole adduct formation in axonal cytoskeletal protein. Neurotoxicology 8(1): 199-210
Kurihara, K.; Kita, K.; Hattori, T.; Hirayama, K. 1986: N-Hexane polyneuropathy due to sniffing bond G10--clinical and electron microscopic findings. No to Shinkei 38(11): 1011-1017
Huang, C.C.; Shih, T.S.; Cheng, S.Y.; Chen, S.S.; Tchen, P.H. 1991: N-Hexane polyneuropathy in a ball-manufacturing factory. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 33(2): 139-142
Kasahara, M.; Suzuki, H.; Takeuchi, Y.; Hara, I.; Ikeda, M. 1987: N-Hexane, benzene and other aromatic components in petroleum distillate solvents in Japan. Industrial Health 25(4): 205-213
Walker, E.A.; Castegnaro, M.; Griciute, L. 1979: N-Nitrosamines in the diet of experimental animals. Cancer Letters 6(3): 175-178
Balasubramanian, M.; Chandra, R.; Sharma, M.C.; Mukerji, S. 1979: N-Tetracosanoic (lignoceric) acid from Penicillium nigricans mycelium. Indian Journal of Experimental Biology 17(6): 621-622
Medina, J.H.; de Stein, M.L.; De Robertis, E. 1989: N-[3H]butyl-beta-carboline-3-carboxylate, a putative endogenous ligand, binds preferentially to subtype 1 of central benzodiazepine receptors. Journal of Neurochemistry 52(3): 665-670
Olczyk, C. 1978: N-alkanes as a substratum for riboflavin production. I. Investigations of the dynamics of the flavinogenesis in chosen yeasts of the genus candida. Polish Journal of Pharmacology and Pharmacy 30(1): 83-88
Küster, W.; Melnik, B.; Plewig, G. 1991: N-alkanes in the skin. Archives of Dermatology 127(11): 1727-1728
Gladhaug, I.P.; Christoffersen, T. 1989: N-butyrate and dexamethasone synergistically modulate the surface expression of epidermal growth factor receptors in cultured rat hepatocytes. Febs Letters 243(1): 21-24
Shah, S.; Lance, P.; Smith, T.J.; Berenson, C.S.; Cohen, S.A.; Horvath, P.J.; Lau, J.T.; Baumann, H. 1992: N-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells. Journal of Biological Chemistry 267(15): 10652-10658
Zórad, S.; Klimes, I.; Svábová, E.; Mitková, A.; Macho, L. 1987: n-heptane and n-hexane enhance in a dose-dependent manner insulin binding to erythrocytes and its degradation. General Physiology and Biophysics 6(2): 197-201
Ichikawa, Y.; Ogawa, Y.; Okayama, A.; Lin, K.M.; Sugimoto, K.; Goto, S. 1987: N-hexane exposure and urinary concentration of 2,5-hexanedion. Medical Journal of Osaka University 36(3-4): 29-34
Pezzoli, G.; Ricciardi, S.; Masotto, C.; Mariani, C.B.; Carenzi, A. 1990: N-hexane induces parkinsonism in rodents. Brain Research 531(1-2): 355-357
Kimura, I.; Tsuneki, H.; Kondoh, T.; Kimura, M. 1992: NACh receptor-activity modulating intracellular Ca2+ (RAMIC); its finding, properties and roles. Advances in Experimental Medicine and Biology 311: 319-321
Salmons, B.; Erfle, V.; Brem, G.; Günzburg, W.H. 1990: Naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region. Journal of Virology 64(12): 6355-6359
Kernan, M.J.; Kuroda, M.I.; Kreber, R.; Baker, B.S.; Ganetzky, B. 1991: Napts, a mutation affecting sodium channel activity in Drosophila, is an allele of mle, a regulator of X chromosome transcription. Cell 66(5): 949-959
Sodergren, E.J.; DeMoss, J.A. 1988: Nari region of the Escherichia coli nitrate reductase (nar) operon contains two genes. Journal of Bacteriology 170(4): 1721-1729
Park, Y.C.; Kurita, T. 1986: Neurogenic bladder and urinary tract infections. Nihon Rinsho. Japanese Journal of Clinical Medicine 44(12): 2683-2687
Sefton, B.M. 1988: Neus about c-erb-B-2 and HER2. Trends in Genetics: Tig 4(9): 247-248
Hoover, T.R.; Shah, V.K.; Roberts, G.P.; Ludden, P.W. 1986: NifV-dependent, low-molecular-weight factor required for in vitro synthesis of iron-molybdenum cofactor of nitrogenase. Journal of Bacteriology 167(3): 999-1003
Burger, G.; Strauss, J.; Scazzocchio, C.; Lang, B.F. 1991: NirA, the pathway-specific regulatory gene of nitrate assimilation in Aspergillus nidulans, encodes a putative GAL4-type zinc finger protein and contains four introns in highly conserved regions. Molecular and Cellular Biology 11(11): 5746-5755
Fu, Y.H.; Marzluf, G.A. 1990: Nit-2, the major nitrogen regulatory gene of Neurospora crassa, encodes a protein with a putative zinc finger DNA-binding domain. Molecular and Cellular Biology 10(3): 1056-1065
Fu, Y.H.; Marzluf, G.A. 1990: Nit-2, the major positive-acting nitrogen regulatory gene of Neurospora crassa, encodes a sequence-specific DNA-binding protein. Proceedings of the National Academy of Sciences of the United States of America 87(14): 5331-5335
Yuan, G.F.; Fu, Y.H.; Marzluf, G.A. 1991: Nit-4, a pathway-specific regulatory gene of Neurospora crassa, encodes a protein with a putative binuclear zinc DNA-binding domain. Molecular and Cellular Biology 11(11): 5735-5745
Lewin, A.; Cervantes, E.; Chee-Hoong, W.; Broughton, W.J. 1990: NodSU, two new nod genes of the broad host range Rhizobium strain NGR234 encode host-specific nodulation of the tropical tree Leucaena leucocephala. Molecular Plant-Microbe Interactions: Mpmi 3(5): 317-326
Krishnan, H.B.; Pueppke, S.G. 1991: NolC, a Rhizobium fredii gene involved in cultivar-specific nodulation of soybean, shares homology with a heat-shock gene. Molecular Microbiology 5(3): 737-745
Chiou, S.S.; Chang, T.T.; Perng, J.J.; Chen, T.S. 1987: Non-Hodgkin's lymphoma treated with modified LSA2-L2 protocol--a clinical experience and case report. Gaoxiong Yi Xue Ke Xue Za Zhi 3(6): 419-424
Rakonjac, J.; Milic, M.; Ajdic-Predic, D.; Santos, D.; Ivanisevic, R.; Savic, D.J. 1992: Nov: a new genetic locus that affects the response of Escherichia coli K-12 to novobiocin. Molecular Microbiology 6(11): 1547-1553
Toma, S.; Del Bue, M.; Pirola, A.; Grandi, G. 1986: NprR1 and nprR2 regulatory regions for neutral protease expression in Bacillus subtilis. Journal of Bacteriology 167(2): 740-743
Dieken, E.S.; Meese, E.U.; Miesfeld, R.L. 1990: Nti glucocorticoid receptor transcripts lack sequences encoding the amino-terminal transcriptional modulatory domain. Molecular and Cellular Biology 10(9): 4574-4581
Gordon, A.S.; Milfay, D. 1986: Nu 1, a Mr 43,000 component of postsynaptic membranes, is a protein kinase. Proceedings of the National Academy of Sciences of the United States of America 83(12): 4172-4174
Olins, A.L. 1978: nu bodies are close-packed in chromatin fibers. Cold Spring Harbor Symposia on Quantitative Biology 42 Pt 1: 325-329
Howze, G.B.; Hsie, A.W.; Olins, A.L. 1976: Nu-Bodies in mitotic chromatin. Experimental Cell Research 100(2): 424-428
Uemura, T.; Shepherd, S.; Ackerman, L.; Jan, L.Y.; Jan, Y.N. 1989: Numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos. Cell 58(2): 349-360
Tsugawa, A.; Saito, M.; Court, D.L.; Nakamura, Y. 1988: NusA amber mutation that causes temperature-sensitive growth of Escherichia coli. Journal of Bacteriology 170(2): 908-915
McKiernan, P.; Doyle, D.A.; Duffy, G.J.; Towers, R.P.; Duff, F.A.; O'Donovan, D.K. 1978: O,p'--DDD and adrenal carcinoma. Irish Journal of Medical Science 147(12): 437-440
Hogan, T.F.; Citrin, D.L.; Johnson, B.M.; Nakamura, S.; Davis, T.E.; Borden, E.C. 1978: O,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement. Cancer 42(5): 2177-2181
Lund, B.O.; Klasson-Wehler, E.; Brandt, I. 1986: O,p'-DDD in the mouse lung: selective uptake, covalent binding and effect on drug metabolism. Chemico-Biological Interactions 60(2): 129-141
Galand, P.; Mairesse, N.; Degraef, C.; Rooryck, J. 1987: O,p'-DDT (1,1,1-trichloro-2(p-chlorophenyl) 2-(o-chlorophenyl) ethane is a purely estrogenic agonist in the rat uterus in vivo and in vitro. Biochemical Pharmacology 36(3): 397-400
Turner, R.T.; Eliel, L.P. 1978: O,p'-DDT as an estrogen: an evaluation of its ability to compete with 3H-estradiol for nuclear estrogen receptor sites in the quail oviduct. Bulletin of Environmental Contamination and Toxicology 19(2): 139-142
Becker, D.; Schumacher, O.P. 1975: O,p'DDD therapy in invasive adrenocortical carcinoma. Annals of Internal Medicine 82(5): 677-679
Nash, A.S.; Bogan, J.A. 1978: O,p-DDD in the treatment of Cushing's disease. Veterinary Record 102(21): 470
Iavorskiĭ, M.P. 1976: O- and m-dinitrobenzenes and their derivatives as reagents in the analysis of organic drugs. Farmatsevtychnyi Zhurnal 31(5): 26-29
Bull, J.M.; Strebel, F.R.; Sunderland, B.A.; Bulger, R.E.; Edwards, M.; Siddik, Z.H.; Newman, R.A. 1988: O-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment. Cancer Research 48(8): 2239-2244
Prabhakaran, K.; Harris, E.B.; Kirchheimer, W.F. 1975: O-Diphenoloxidase of Mycobacterium leprae separated from infecected armadillo tissues. Infection and Immunity 12(2): 267-269
Longo, C.; Garrido, B.; Zalba, G.; López-Moratalla, N.; Santiago, E. 1992: O-Iodosobenzoic oxidation and cleavage of myosin subfragment 1. International Journal of Biochemistry 24(1): 133-143
Kozlowski, R.; Ehrhard, P.; Fischli, W.; Osterrieder, W.; Holck, M. 1986: O-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel. Journal of Pharmacology and Experimental Therapeutics 238(3): 1084-1091
Lambrecht, G.; Gmelin, G.; Rafeiner, K.; Strohmann, C.; Tacke, R.; Mutschler, E. 1988: O-Methoxy-sila-hexocyclium: a new quaternary M1-selective muscarinic antagonist. European Journal of Pharmacology 151(1): 155-156
Hengstenberg, W.; Morse, M.L. 1975: O-Nitrophenyl-beta-D-galactopyranoside 6-phosphate. Methods in Enzymology 41: 119-120
Berlutti, F.; Dainelli, B.; Martini, A.; Thaller, M.C. 1986: O-Nitrophenyl-beta-D-galactopyranoside-urease-indole broth, a new composite tube medium for Salmonella screening. Journal of Clinical Microbiology 24(4): 650-651
Kimura, K.; Nakano, Y.; Matsuoka, K. 1989: O-Phosphotyrosyl glutamine synthetase: modification of the nucleotide ligation site of adenylylated glutamine synthetase. Journal of Biochemistry 105(1): 84-87
Joys, T.M.; Kim, H. 1979: O-Phthalaldehyde and the fluorogenic detection of peptides. Analytical Biochemistry 94(2): 371-377
Maralihalli, G.B.; Bhagwat, A.S. 1990: O-Phthalaldehyde as a probe in the active site of phosphoenolpyruvate carboxylase. Indian Journal of Biochemistry and Biophysics 27(3): 141-145
Jacobs, W.A. 1987: O-Phthalaldehyde-sulfite derivatization of primary amines for liquid chromatography-electrochemistry. Journal of Chromatography 392: 435-441
Sieweke, H.J.; Leistner, E. 1991: O-Succinylbenzoate: coenzyme a ligase, an enzyme involved in menaquinone (vitamin K2) biosynthesis, displays broad specificity. Zeitschrift für Naturforschung. C Journal of Biosciences 46(7-8): 585-590
Cai, S.X.; Keana, J.F. 1991: O-acetamidophenylboronate esters stabilized toward hydrolysis by an intramolecular O-B interaction: potential linkers for selective bioconjugation via vicinal diol moieties of carbohydrates. Bioconjugate Chemistry 2(5): 317-322
Nassi-Calò, L.; Mello-Filho, C.; Meneghini, R. 1989: O-phenanthroline protects mammalian cells from hydrogen peroxide-induced gene mutation and morphological transformation. Carcinogenesis 10(6): 1055-1057
Zhang, Z.Y. 1979: Observations of liver function in patients with long term administration of chlorpromazine. Zhonghua Shen Jing Jing Shen Ke Za Zhi 12(2): 107-108
Andziak, J. 1992: Occurrence of mannose- resistant adhesins MRHA in E.Coli strains isolated from children with diarrhea. Medycyna Doswiadczalna i Mikrobiologia 44(1-2): 13-19
Budowski, P. 1988: Omega 3-fatty acids in health and disease. World Review of Nutrition and Dietetics 57: 214-274
Miura, Y.; Hisaki, H.; Ueta, N. 1978: Omega- and (omega--1)-hydroxylation of fatty acids by frog liver microsomes. Substrate specificity and other properties. Biochimica et Biophysica Acta 531(2): 149-157
Holm, K.A.; Koop, D.R.; Coon, M.J.; Theoharides, A.D.; Kupfer, D. 1985: Omega-1 and omega-2 hydroxylation of prostaglandins by rabbit hepatic microsomal cytochrome P-450 isozyme 6. Archives of Biochemistry and Biophysics 243(1): 135-143
Rabinovitch, M.A.; Kalff, V.; Allen, R.; Rosenthal, A.; Albers, J.; Das, S.K.; Pitt, B.; Swanson, D.P.; Mangner, T.; Rogers, W.L. 1985: Omega-123I-hexadecanoic acid metabolic probe of cardiomyopathy. European Journal of Nuclear Medicine 10(5-6): 222-227
Urquhart, R.; Chan, R.Y.; Li, Q.T.; Tilley, L.; Grieser, F.; Sawyer, W.H. 1992: Omega-6 and omega-3 fatty acids: monolayer packing and effects on bilayer permeability and cholesterol exchange. Biochemistry International 26(5): 831-841
Bindokas, V.P.; Adams, M.E. 1989: Omega-Aga-I: a presynaptic calcium channel antagonist from venom of the funnel web spider, Agelenopsis aperta. Journal of Neurobiology 20(4): 171-188
Yonaha, K.; Toyama, S.; Soda, K. 1987: Omega-Amino acid-pyruvate aminotransferase. Methods in Enzymology 143: 500-504
Horne, W.A.; Hawrot, E.; Tsien, R.W. 1991: Omega-Conotoxin GVIA receptors of Discopyge electric organ. Characterization of omega-conotoxin binding to the nicotinic acetylcholine receptor. Journal of Biological Chemistry 266(21): 13719-13725
Werth, J.L.; Hirning, L.D.; Thayer, S.A. 1991: Omega-Conotoxin exerts functionally distinct low and high affinity effects in the neuronal cell line NG108-15. Molecular Pharmacology 40(5): 742-749
Sher, E.; Biancardi, E.; Pollo, A.; Carbone, E.; Li, G.; Wollheim, C.B.; Clementi, F. 1992: Omega-Conotoxin-sensitive, voltage-operated Ca2+ channels in insulin-secreting cells. European Journal of Pharmacology 216(3): 407-414
Ranise, A.; Bondavalli, F.; Bruno, O.; Schenone, P.; Cenicola, M.L.; Donnoli, D.; Lampa, E.; Rossi, F. 1991: Omega-Dialkylaminoalkyl esters of 3-dialkylamino-4,7,7-trimethyl-N-phenylbicyclo[2.2.1] hept-2-ene-2-iminothiolic acids with local anesthetic activity. Farmaco 46(9): 1033-1041
Ranise, A.; Bondavalli, F.; Bruno, O.; Schenone, S.; D'Amico, M.; Parrillo, C.; Marrazzo, R.; Rossi, F. 1992: Omega-Dialkylaminoalkyl esters of N-phenyl aminethiocarboximidic acids with local anesthetic and other activities. Farmaco 47(10): 1263-1283
Mariani, E.; Bargagna, A.; Longobardi, M.; Schenone, P.; Losasso, C.; Donnoli, D.; Carnevale, M.; Marmo, E. 1991: Omega-Dialkylaminoalkyl ethers of 5-(arylmethylene)-1,3,3-trimethyl-2- oxabicyclo[2.2.2]octan-6-hydroxyimines with platelet antiaggregating and other activities. Farmaco 46(1): 85-98
Schenone, S.; Ranise, A.; Bruno, O.; Bondavalli, F.; Losasso, C.; Donnoli, D.; Cenicola, M.L.; Marmo, E. 1990: Omega-Dialkylaminoalkyl ethers of 5-endo-dialkylamino-1,3,3-trimethyl-2-oxabicyclo [2.2.2]octan-6-hydroxyimines with platelet antiaggregating, antiarrhythmic and local anesthetic activities. Farmaco 45(9): 1013-1025
Schenone, S.; Bruno, O.; Ranise, A.; Bondavalli, F.; Cenicola, M.L.; Losasso, C.; Carnevale, M.; Ottavo, R.; D'Antonio, M. 1990: Omega-Dialkylaminoalkyl ethers of 6-(benzyl or phenyl)-1,3,3-trimethyl-2-oxabicyclo [2.2.2]octan-6-ol with platelet antiaggregating and local anesthetic activities. Farmaco 45(12): 1309-1325
Wertz, P.W.; Downing, D.T. 1989: Omega-Hydroxyacid derivatives in the epidermis of several mammalian species. Comparative Biochemistry and Physiology. B Comparative Biochemistry 93(2): 265-269
Murakami, H.; Kobayashi, J.; Masuda, T.; Morooka, N.; Ueno, Y. 1987: Omega-Hydroxyemodin, a major hepatic metabolite of emodin in various animals and its mutagenic activity. Mutation Research 180(2): 147-153
Okita, R.T.; Soberman, R.J.; Bergholte, J.M.; Masters, B.S.; Hayes, R.; Murphy, R.C. 1987: Omega-Hydroxylation of 15-hydroxyeicosatetraenoic acid by lung microsomes from pregnant rabbits. Molecular Pharmacology 32(5): 706-709
Pinot, F.; Salaün, J.P.; Bosch, H.; Lesot, A.; Mioskowski, C.; Durst, F. 1992: Omega-Hydroxylation of Z9-octadecenoic, Z9,10-epoxystearic and 9,10-dihydroxystearic acids by microsomal cytochrome P450 systems from Vicia sativa. Biochemical and Biophysical Research Communications 184(1): 183-193
Wahle, K.W.; Davies, N.T.; Paterson, S.M. 1977: Omega-Hydroxylation of fatty acids by microsomal preparations from rat and sheep tissues. Proceedings of the Nutrition Society 36(1): 30a
Otto, C.A.; Lee, H.; Mangner, T.J.; Wieland, D.M. 1986: Omega-Iodophenyl fatty acids: a convenient method of radioiodination. International Journal of Radiation Applications and Instrumentation. Part A Applied Radiation and Isotopes 37(3): 205-210
Powell, W.S. 1978: Omega-Oxidation of prostaglandins by lung and liver microsomes. Changes in enzyme activity induced by pregnancy, pseudopregnancy, and progesterone treatment. Journal of Biological Chemistry 253(19): 6711-6716
Labaudinière, R.; Dereu, N.; Cavy, F.; Guillet, M.C.; Marquis, O.; Terlain, B. 1992: Omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. Journal of Medicinal Chemistry 35(23): 4315-4324
Labaudinière, R.; Hendel, W.; Terlain, B.; Cavy, F.; Marquis, O.; Dereu, N. 1992: Omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. Journal of Medicinal Chemistry 35(23): 4306-4314
Wada, F. 1978: Omega-oxidation of fatty acid. SEIKAGAKU. Journal of Japanese Biochemical Society 50(8): 576-582
Lakey, J.H.; Lea, E.J.; Pattus, F. 1991: OmpC mutants which allow growth on maltodextrins show increased channel size and greater voltage sensitivity. Febs Letters 278(1): 31-34
Grodberg, J.; Dunn, J.J. 1988: OmpT encodes the Escherichia coli outer membrane protease that cleaves T7 RNA polymerase during purification. Journal of Bacteriology 170(3): 1245-1253
Okawa, Y.; Yokota, R.; Yamauchi, A. 1979: On the extracellular sheath of dermal melanocytes in nevus fusco-ceruleus acromiodeltoideus (Ito) and Mongolian spot. An ultrastructural study. Journal of Investigative Dermatology 73(3): 224-230
Wharton, K.A.; Yedvobnick, B.; Finnerty, V.G.; Artavanis-Tsakonas, S. 1985: Opa: a novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster. Cell 40(1): 55-62
Geetha, K.B.; Lending, C.R.; Lopes, M.A.; Wallace, J.C.; Larkins, B.A. 1991: Opaque-2 modifiers increase gamma-zein synthesis and alter its spatial distribution in maize endosperm. Plant Cell 3(11): 1207-1219
Andrews, J.C.; Short, S.A. 1986: Opp-lac Operon fusions and transcriptional regulation of the Escherichia coli trp-linked oligopeptide permease. Journal of Bacteriology 165(2): 434-442
Neuville, P.; Aigle, M. 1992: Ore2, a mutation affecting proline biosynthesis in the yeast Saccharomyces cerevisiae, leads to a cdc phenotype. Molecular and General Genetics: Mgg 234(2): 193-200
McIntire, S.A.; Dempsey, W.B. 1987: OriT sequence of the antibiotic resistance plasmid R100. Journal of Bacteriology 169(8): 3829-3832
Cheever, K.L.; DeBord, D.G.; Swearengin, T.F.; Booth-Jones, A.D. 1992: Ortho-toluidine blood protein adducts: HPLC analysis with fluorescence detection after a single dose in the adult male rat. Fundamental and Applied Toxicology: Official Journal of the Society of Toxicology 18(4): 522-531
Beretta, E.; Piatti, E.; Dachà, M.; Fornaini, G. 1976: Oscillatory phenomena and its relationship with glucose-1, 6-P2 synthesis and the erythrocyte glycolysis. Italian Journal of Biochemistry 25(3): 264-266
Greenburg, R.R.; Risebrough, R.W.; Anderson, D.W. 1979: P,p'-DDE-induced changes in the organic and inorganic structure of eggshells of the mallard, Anas platyrhynchos. Toxicology and Applied Pharmacology 48(2): 279-286
Magnussen, I. 1985: P,p'-DDT-induced myoclonus in mice: the effect of enhanced 5-HT neurotransmission. Acta Pharmacologica et Toxicologica 56(2): 87-90
Pratt, J.A.; Rothwell, J.; Jenner, P.; Marsden, C.D. 1986: P,p'-DDT-induced myoclonus in the rat and its application as an animal model of 5-HT-sensitive action myoclonus. Advances in Neurology 43: 577-588
Hwang, E.C.; Van Woert, M.H. 1978: P,p'-DDT-induced neurotoxic syndrome: experimental myoclonus. Neurology 28(10): 1020-1025
Conaway, C.C.; Madhukar, B.V.; Matsumura, F. 1977: P,p'-DDT: studies on induction mechanisms of microsomal enzymes in rat liver systems. Environmental Research 14(2): 305-321
Wong, Y.H.; Winer, F.B.; Frey, P.A. 1979: P-(Bromoacetamido)phenyl uridyl pyrophosphate: an active-site-directed irreversible inhibitor for uridine diphosphate galactose 4-epimerase. Biochemistry 18(24): 5332-5336
Benga, G.; Popescu, O.; Pop, V.I.; Holmes, R.P. 1986: P-(Chloromercuri)benzenesulfonate binding by membrane proteins and the inhibition of water transport in human erythrocytes. Biochemistry 25(7): 1535-1538
Kwon, C.H.; Blanco, D.R.; Baturay, N. 1992: P-(Methylsulfinyl)phenyl nitrogen mustard as a novel bioreductive prodrug selective against hypoxic tumors. Journal of Medicinal Chemistry 35(11): 2137-2139
Hayward, C.P.; Smith, J.W.; Horsewood, P.; Warkentin, T.E.; Kelton, J.G. 1991: P-155, a multimeric platelet protein that is expressed on activated platelets. Journal of Biological Chemistry 266(11): 7114-7120
Grady, R.W.; Bienen, E.J.; Clarkson, A.B. 1986: P-Alkyloxybenzhydroxamic acids, effective inhibitors of the trypanosome glycerol-3-phosphate oxidase. Molecular and Biochemical Parasitology 19(3): 231-240
Green, J.M.; Nichols, B.P. 1991: P-Aminobenzoate biosynthesis in Escherichia coli. Purification of aminodeoxychorismate lyase and cloning of pabC. Journal of Biological Chemistry 266(20): 12971-12975
Zalkin, H. 1985: P-Aminobenzoate synthase. Methods in Enzymology 113: 293-297
Ye, Q.Z.; Liu, J.; Walsh, C.T. 1990: P-Aminobenzoate synthesis in Escherichia coli: purification and characterization of PabB as aminodeoxychorismate synthase and enzyme X as aminodeoxychorismate lyase. Proceedings of the National Academy of Sciences of the United States of America 87(23): 9391-9395
Kane, J.F.; O'Brien, H.D. 1975: P-Aminobenzoate-p-aminobenzoate. Journal of Bacteriology 123(3): 1131-1138
Zhang, Y.; Merali, S.; Meshnick, S.R. 1992: P-Aminobenzoic acid transport by normal and Plasmodium falciparum-infected erythrocytes. Molecular and Biochemical Parasitology 52(2): 185-194
Benesch, R.E.; Kwong, S.; Hudson, B.B.; Krumdieck, C.L. 1988: P-Aminobenzoylpolyglutamates with hydrophobic end groups. a new class of inhibitors of hemoglobin S polymerization. Journal of Biological Chemistry 263(1): 69-71
Cloutier, M.M.; Guernsey, L. 1992: P-Aminohippurate transport in airways: competitive inhibition. American Journal of Physiology 262(5 Part 1): L555-L559
Eveloff, J. 1987: P-Aminohippurate transport in basal-lateral membrane vesicles from rabbit renal cortex: stimulation by pH and sodium gradients. Biochimica et Biophysica Acta 897(3): 474-480
Cloutier, M.M.; Lesniak, K.M. 1985: P-Aminohippurate transport in canine tracheal epithelium. Journal of Applied Physiology 59(5): 1585-1589
Eveloff, J.; Kinne, R.; Kinter, W.B. 1979: P-Aminohippuric acid transport into brush border vesicles isolated from flounder kidney. American Journal of Physiology 237(4): F291-F298
Street, K.W.; Schenk, G.H. 1979: P-Aminophenol fluorescence and determination in the presence of acetaminophen. Journal of Pharmaceutical Sciences 68(10): 1306-1309
Hayward, N.K.; Lavin, M.F. 1985: P-Aminophenol induced DNA damage and cytotoxicity enhanced by autoxidation. Life Sciences 36(21): 2039-2046
Kawahara, R.S.; Byington, K.H.; Bylund, D.B. 1985: P-Azidoclonidine: a photoaffinity label for the alpha 2-adrenoceptor. European Journal of Pharmacology 117(1): 43-50
Ricardo, M.J.; Cebra, J.J. 1977: P-Azobenzenearsonate antibody. Methods in Enzymology 46: 492-501
Becker, M.J.; Ray, A.; Andersson, L.C.; Makela, O. 1975: P-Azobenzenearsonate-L-tyrosine-mediated helper function in immune responses of guinea pigs and rats. European Journal of Immunology 5(4): 262-266
Kauer, J.C.; Erickson-Viitanen, S.; Wolfe, H.R.; DeGrado, W.F. 1986: P-Benzoyl-L-phenylalanine, a new photoreactive amino acid. Photolabeling of calmodulin with a synthetic calmodulin-binding peptide. Journal of Biological Chemistry 261(23): 10695-10700
Daussin, F.; Boschetti, E.; Delmotte, F.; Monsigny, M. 1988: P-Benzylthiocarbamoyl-aspartyl-daunorubicin-substituted polytrisacryl. a new drug acid-labile arm-carrier conjugate. European Journal of Biochemistry 176(3): 625-628
Knoll, J.; Knoll, B. 1975: P-Bromo-methamphetamine (V-III) induced improvement of learning ability in rats. International Journal of Neurology 10(1-4): 198-221
Ehret-Sabatier, L.; Goeldner, M.P.; Hirth, C.G. 1991: P-Butyroxybenzenediazonium fluoroborate, substrate of acetylcholinesterase and butyrylcholinesterase, discriminates between the two enzymes by a specific affinity labelling. Biochimica et Biophysica Acta 1076(1): 137-142
Simon, B.; Kather, H. 1975: P-CMB-dextran T 10. a useful tool in evaluating the functional importance of superficial SH-groups in rat adipocytes. Agents and Actions 5(2): 125-127
Davis, M.; Sheard, M.H. 1976: P-Chloroamphetamine (PCA): acute and chronic effects on habituation and sensitization of the acoustic startle response in rats. European Journal of Pharmacology 35(2): 261-273
Burke, D.H.; Brooks, J.C.; Ryan, R.P.; Treml, S.B. 1979: P-Chloroamphetamine antagonism of cobaltous chloride-induced hypothermia in mice. European Journal of Pharmacology 60(2-3): 241-243
Fuller, R.W.; Snoddy, H.D.; Perry, K.W. 1987: P-Chloroamphetamine formation responsible for long-term depletion of brain serotonin after N-cyclopropyl-p-chloroamphetamine injection in rats. Life Sciences 40(19): 1921-1927
Rudnick, G.; Wall, S.C. 1992: P-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31(29): 6710-6718
Sharp, T.; Zetterström, T.; Christmanson, L.; Ungerstedt, U. 1986: P-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neuroscience Letters 72(3): 320-324
Alesci, R.; Porciatti, V.; Sebastiani, L.; Bagnoli, P. 1989: P-Chloroamphetamine treatment modifies evoked responses to sinusoidal gratings in the pigeon optic tectum. Visual Neuroscience 2(2): 147-152
Saito, T.R.; Hokao, R.; Wakafuji, Y.; Aoki, S.; Dohbutsu, A.; Kiyosawa, I.; Amao, H.; Sugiyama, M.; Takahashi, K.W. 1991: P-Chloroamphetamine-induced ejaculation and the 22-kHz vocalization of the male rat. Jikken Dobutsu. Experimental Animals 40(1): 117-119
DeMesquita, S. 1985: P-Chloroamphetamine: effect on sleep and respiration in the rat. Pharmacology Biochemistry and Behavior 22(5): 889-891
Silverman, P.B.; Ho, B.T. 1979: P-Chloroamphetamine: evaluation of a brain metabolite. Communications in Psychopharmacology 3(5): 291-294
Sheard, M.H.; Davis, M. 1976: P-Chloroamphetamine: short and long term effects upon shock-elicited aggression. European Journal of Pharmacology 40(2): 295-302
Haas, M.; Schmidt, W.F. 1985: P-Chloromercuribenzenesulfonic acid stimulation of chloride-dependent sodium and potassium transport in human red blood cells. Biochimica et Biophysica Acta 814(1): 43-49
Kunimoto, M.; Shibata, K.; Miura, T. 1987: P-Chloromercuribenzoate-induced dissociation of cytoskeletal proteins in red blood cells of rats. Biochimica et Biophysica Acta 905(2): 257-267
Robinson, S.P.; Wiskich, J.T. 1977: P-Chloromercuriphenyl sulphonic acid as a specific inhibitor of the phosphate transporter in isolated chloroplasts. Febs Letters 78(2): 203-206
Filipovic, I.; Buddecke, E. 1977: P-Chlorophenoxyisobutyrate enhanced retention of homologous lipoproteins by human aortic smooth muscle cells. Lipids 12(12): 1069-1077
Booth, J.E.; van der Schoot, P. 1979: P-Chlorophenylalanine and copulatory behaviour in male rats, castrated and treated with dihydrotestosterone neonatally. Journal of Endocrinology 80(2): 44p-45p
Cronin, M.J. 1976: P-Chlorophenylalanine hyperthermia in a warm environment: reversal with 5-hydroxytryptophan. Brain Research 112(1): 194-199
Alexander, G.J.; Kopeloff, L.M. 1977: P-Chlorophenylalanine-mediated decrease in susceptibility to audiogenic seizures in inbred mice. Neuropharmacology 16(6): 405-409
Miller, M.R.; McClure, D.; Shiman, R. 1975: P-Chlorphenylalanine effect on phenylalanine hydroxylase in hepatoma cells in culture. Journal of Biological Chemistry 250(3): 1132-1140
D'Ari, L.; Barker, H.A. 1985: P-Cresol formation by cell-free extracts of Clostridium difficile. Archives of Microbiology 143(3): 311-312
McIntire, W.; Hopper, D.J.; Singer, T.P. 1985: P-Cresol methylhydroxylase. Assay and general properties. Biochemical Journal 228(2): 325-335
DeFrank, J.J.; Ribbons, D.W. 1977: P-Cymene pathway in Pseudomonas putida: ring cleavage of 2,3-dihydroxy-p-cumate and subsequent reactions. Journal of Bacteriology 129(3): 1365-1374
Wilchek, M.; Ben-Hur, H.; Bayer, E.A. 1986: P-Diazobenzoyl biocytin--a new biotinylating reagent for the labeling of tyrosines and histidines in proteins. Biochemical and Biophysical Research Communications 138(2): 872-879
Rothenberg, J.M.; Wilchek, M. 1988: P-Diazobenzoyl-biocytin: a new biotinylating reagent for DNA. Nucleic Acids Research 16(14b): 7197
Cannon, J.G.; Amoo, V.E.; Long, J.P.; Bhatnagar, R.K.; Flynn, J.R. 1986: P-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects. Journal of Medicinal Chemistry 29(12): 2529-2534
Duckles, S.P. 1990: P-Fluoro-hexahydro-sila-difenidol: affinity for vascular muscarinic receptors. European Journal of Pharmacology 185(2-3): 227-230
Boquist, L. 1979: P-Hydroxymercuribenzoate-induced hyperglycemia: influence of pre- and post-treatment with L-leucine, tolbutamide, D-mannoheptulose, insulin and alloxan. Journal of Endocrinological Investigation 2(4): 413-417
Metz, S.A. 1986: P-Hydroxymercuribenzoic acid inhibits arachidonic acid esterification into two distinct pools and stimulates insulin release in intact rat islets. Journal of Pharmacology and Experimental Therapeutics 238(3): 809-818
Knight, P.; Offer, G. 1978: P-NN'-phenylenebismaleimide, a specific cross-linking agent for F-actin. Biochemical Journal 175(3): 1023-1032
Kasafírek, E.; Fric, P.; Slabý, J.; Malis, F. 1976: P-Nitroanilides of 3-carboxypropionyl-peptides. their cleavage by elastase, trypsin, and chymotrypsin. European Journal of Biochemistry 69(1): 1-13
Azarian, A.V.; Agatian, G.L.; Galoian, A.A. 1987: P-Nitroanilides of amino acids and peptides and fluorescence peptide with inner fluorescence quenching as substrates for cathepsins H, B, D and high molecular weight aspartic peptidase in the brain. Biokhimiia 52(12): 2033-2037
Jung, C.; Sklenar, G.; Ristau, O.; Pommerening, K.; Rein, H. 1987: P-Nitrophenetole deethylase activity of rat liver microsomes entrapped in polyelectrolyte capsules. Journal of Microencapsulation 4(1): 1-9
Reinke, L.A.; Moyer, M.J. 1985: P-Nitrophenol hydroxylation. a microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(5): 548-552
Hosie, L.; Sutton, L.D.; Quinn, D.M. 1987: P-Nitrophenyl and cholesteryl-N-alkyl carbamates as inhibitors of cholesterol esterase. Journal of Biological Chemistry 262(1): 260-264
Hinson, J.A.; Mays, J.B. 1986: P-Nitrosophenetole: a reactive intermediate of phenacetin that binds to protein. Advances in Experimental Medicine and Biology 197: 691-696
Soto, A.M.; Justicia, H.; Wray, J.W.; Sonnenschein, C. 1991: P-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environmental Health Perspectives 92: 167-173
Ioannou, Y.M.; Matthews, H.B. 1985: P-Phenylenediamine dihydrochloride: comparative disposition in male and female rats and mice. Journal of Toxicology and Environmental Health 16(2): 299-313
Ekborg, G.; Glaudemans, C.P. 1985: P-Trifluoroacetamidophenyl O-alpha-D-mannopyranosyl-(1----3)-O-[alpha-D-mannopyranosyl- (1----6)]-beta-D-mannopyranoside. Carbohydrate Research 142(2): 213-221
Becú-Villalobos, D.; Lacau de Mengido, I.M.; Libertun, C. 1985: P-Tyramine, a natural amine, inhibits prolactin release in vivo. Endocrinology 116(5): 2044-2048
Bouley, E.; Teulon, J.M.; Cazes, M.; Cloarec, A.; Deghenghi, R. 1986: P-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agents. Journal of Medicinal Chemistry 29(1): 100-103
Gerhardt, M.A.; Wade, S.M.; Neubig, R.R. 1990: P-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor. Molecular Pharmacology 38(2): 214-221
Baron, B.M.; Siegel, B.W. 1990: P-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors. Molecular Pharmacology 38(3): 348-356
Roux, B.; Walsh, C.T. 1992: P-aminobenzoate synthesis in Escherichia coli: kinetic and mechanistic characterization of the amidotransferase PabA. Biochemistry 31(30): 6904-6910
Schwartz, G.J.; Goldsmith, D.I.; Fine, L.G. 1978: p-aminohippurate transport in the proximal straight tubule: development and substrate stimulation. Pediatric Research 12(7): 793-796
Klos, C.; Koob, M.; Kramer, C.; Dekant, W. 1992: P-aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates. Toxicology and Applied Pharmacology 115(1): 98-106
Vorhees, C.V.; Schaefer, G.J.; Barrett, R.J. 1975: P-chloroamphetamine: behavioral effects of reduced cerebral serotonin in rats. Pharmacology Biochemistry and Behavior 3(2): 279-284
Tachikawa, E.; Takahashi, S.; Kashimoto, T. 1989: P-chloromercuribenzoate causes Ca2+-dependent exocytotic catecholamine secretion from cultured bovine adrenal medullary cells. Journal of Neurochemistry 53(1): 19-26
Matsuda, T.; Kanda, T.; Seong, Y.H.; Baba, A.; Iwata, H. 1990: P-chlorophenylalanine attenuates the pituitary-adrenocortical response to 5-HT1A receptor agonists in mice. European Journal of Pharmacology 181(3): 295-297
Hopper, D.J.; Bossert, I.D.; Rhodes-Roberts, M.E. 1991: P-cresol methylhydroxylase from a denitrifying bacterium involved in anaerobic degradation of p-cresol. Journal of Bacteriology 173(3): 1298-1301
DeFrank, J.J.; Ribbons, D.W. 1977: P-cymene pathway in Pseudomonas putida: initial reactions. Journal of Bacteriology 129(3): 1356-1364
Lambrecht, G.; Feifel, R.; Forth, B.; Strohmann, C.; Tacke, R.; Mutschler, E. 1988: P-fluoro-hexahydro-sila-difenidol: the first M2 beta-selective muscarinic antagonist. European Journal of Pharmacology 152(1-2): 193-194
Babudri, N.; Morpurgo, G. 1990: P-fluoro-phenylalanine resistance in Aspergillus nidulans diploid cells: evidence that dominant, lethal mutations are involved. Current Genetics 17(6): 519-522
Fuchs, B.; Ostmeier, H.; Suter, L. 1991: P-glycoprotein expression in malignant melanoma. Journal of Cancer Research and Clinical Oncology 117(2): 168-171
Eisner, T.; Eisner, M. 1990: p-methoxyphenol: chemical basis of stench of a female butterfly. Defense mechanisms of arthropods, No. 91. Die Naturwissenschaften 77(1): 33
Tsujita, T.; Ninomiya, H.; Okuda, H. 1989: P-nitrophenyl butyrate hydrolyzing activity of hormone-sensitive lipase from bovine adipose tissue. Journal of Lipid Research 30(7): 997-1004
Nanjo, F.; Sakai, K.; Usui, T. 1988: P-nitrophenyl penta-N-acetyl-beta-chitopentaoside as a novel synthetic substrate for the colorimetric assay of lysozyme. Journal of Biochemistry 104(2): 255-258
Parry, G.; Farson, D.; Cullen, B.; Bissell, M.J. 1988: P-nitrophenyl-beta-D-xyloside modulates proteoglycan synthesis and secretory differentiation in mouse mammary epithelial cell cultures. In Vitro Cellular and Developmental Biology; Journal of the Tissue Culture Association 24(12): 1217-1222
Senior, B.W. 1978: P-nitrophenylglycerol--a superior antiswarming agent for isolating and identifying pathogens from clinical material. Journal of Medical Microbiology 11(1): 59-61
Maurich, V.; Zacchigna, M.; Pitotti, A. 1991: P-nitrophenyllaurate: a substrate for the high-performance liquid chromatographic determination of lipase activity. Journal of Chromatography 566(2): 453-459
Peace, K.E.; Schriver, R.C. 1987: P-value and power computations in multiple look trials. Journal of Chronic Diseases 40(1): 23-30
Roberts, W.J.; Pan, T.; Elliott, J.I.; Coleman, J.E.; Williams, K.R. 1989: P10 single-stranded nucleic acid binding protein from murine leukemia virus binds metal ions via the peptide sequence Cys26-X2-Cys29-X4-His34-X4-Cys39. Biochemistry 28(26): 10043-10047
Casas-Finet, J.R.; Jhon, N.I.; Maki, A.H. 1988: P10, a low molecular weight single-stranded nucleic acid binding protein of murine leukemia retroviruses, shows stacking interactions of its single tryptophan residue with nucleotide bases. Biochemistry 27(4): 1172-1178
Hayes, N.V.; Rayner, D.A.; Woods, A.; Baines, A.J. 1991: P103 and A60: novel proteins of the neuronal membrane-associated cytoskeleton. Biochemical Society Transactions 19(4): 1042-1048
Capobianco, A.J.; Chang, D.; Mosialos, G.; Gilmore, T.D. 1992: P105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. Journal of Virology 66(6): 3758-3767
Parker, L.L.; Atherton-Fessler, S.; Piwnica-Worms, H. 1992: P107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proceedings of the National Academy of Sciences of the United States of America 89(7): 2917-2921
Brizuela, L.; Draetta, G.; Beach, D. 1987: P13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. EMBO Journal 6(11): 3507-3514
Holtzman, D.M.; Li, Y.; Parada, L.F.; Kinsman, S.; Chen, C.K.; Valletta, J.S.; Zhou, J.; Long, J.B.; Mobley, W.C. 1992: P140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron 9(3): 465-478
Larche, M.; Lamb, J.R.; Ritter, M.A. 1988: P145-MR6: a novel T cell surface molecule with a role in tolerance to self. Advances in Experimental Medicine and Biology 237: 413-417
Springer, T.A.; Miller, L.J.; Anderson, D.C. 1986: P150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. Journal of Immunology 136(1): 240-245
Lanier, L.L.; Arnaout, M.A.; Schwarting, R.; Warner, N.L.; Ross, G.D. 1985: P150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. European Journal of Immunology 15(7): 713-718
Strop, P.; Pavlícková, L.; Stys, D.; Soucek, M.; Urban, J.; Hrusková, O.; Kaprálek, F.; Jecmen, P.; Sedlácek, J.; Kostka, V. 1991: P15gag proteinase of myeloblastosis associated virus: specificity studies with substrate based inhibitors. Advances in Experimental Medicine and Biology 306: 519-523
Sharova, N.; Bukrinskaya, A. 1991: P17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells. Aids Research and Human Retroviruses 7(3): 303-306
Riccardi, A.; Invernizzi, R.; Ucci, G.; Luoni, R.; Danova, M.; Giordano, M.; Zambelli, M.L.; Rastaldi, M.P.; Ascari, E. 1991: P170 in multiple myeloma and acute leukemia. Haematologica 76(Suppl 3): 177-180
Centis, F.; Tagliabue, E.; Uppugunduri, S.; Pellegrini, R.; Martignone, S.; Mastroianni, A.; Ménard, S.; Colnaghi, M.I. 1992: P185 HER2/neu epitope mapping with murine monoclonal antibodies. Hybridoma 11(3): 267-276
Stern, D.F.; Heffernan, P.A.; Weinberg, R.A. 1986: P185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Molecular and Cellular Biology 6(5): 1729-1740
Hudziak, R.M.; Lewis, G.D.; Winget, M.; Fendly, B.M.; Shepard, H.M.; Ullrich, A. 1989: P185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology 9(3): 1165-1172
Scott, G.K.; Dodson, J.M.; Montgomery, P.A.; Johnson, R.M.; Sarup, J.C.; Wong, W.L.; Ullrich, A.; Shepard, H.M.; Benz, C.C. 1991: P185HER2 signal transduction in breast cancer cells. Journal of Biological Chemistry 266(22): 14300-14305
Quian, X.L.; Decker, S.J.; Greene, M.I. 1992: P185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases. Proceedings of the National Academy of Sciences of the United States of America 89(4): 1330-1334
Kern, J.A.; Schwartz, D.A.; Nordberg, J.E.; Weiner, D.B.; Greene, M.I.; Torney, L.; Robinson, R.A. 1990: P185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Research 50(16): 5184-5187
Wildenhain, Y.; Pawson, T.; Blackstein, M.E.; Andrulis, I.L. 1990: P185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2. Oncogene 5(6): 879-883
Turbitt, M.L.; MacKie, R.M. 1985: P19 Antigen in skin and lymph nodes of patient with advanced mycosis fungoides. Lancet 2(8461): 945
Shih, T.Y.; Weeks, M.O.; Young, H.A.; Scolnick, E.M. 1979: P21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation. Journal of Virology 31(2): 546
Backer, J.M.; Weinstein, I.B. 1986: P21 ras proteins and guanine nucleotides modulate the phosphorylation of 36- and 17-kilodalton mitochondria-associated proteins. Proceedings of the National Academy of Sciences of the United States of America 83(17): 6357-6361
Reinstein, J.; Schlichting, I.; Frech, M.; Goody, R.S.; Wittinghofer, A. 1991: P21 with a phenylalanine 28----leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming properties. Journal of Biological Chemistry 266(26): 17700-17706
Stone, J.C.; Vass, W.C.; Willumsen, B.M.; Lowy, D.R. 1988: P21-ras effector domain mutants constructed by "cassette" mutagenesis. Molecular and Cellular Biology 8(8): 3565-3569
Gately, M.K.; Dick, M.D.; Masuno, T.; McCarron, R.M.; Macchi, B. 1985: P215 and p24: two membrane-associated proteins expressed on cloned cytolytic T-cells but not on cloned helper T-cells. Advances in Experimental Medicine and Biology 184: 401-413
Lloyd, A.C.; Paterson, H.F.; Morris, J.D.; Hall, A.; Marshall, C.J. 1989: P21H-ras-induced morphological transformation and increases in c-myc expression are independent of functional protein kinase C. EMBO Journal 8(4): 1099-1104
Duronio, V.; Welham, M.J.; Abraham, S.; Dryden, P.; Schrader, J.W. 1992: P21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proceedings of the National Academy of Sciences of the United States of America 89(5): 1587-1591
Baldari, C.T.; Macchia, G.; Massone, A.; Telford, J.L. 1992: P21ras contributes to HIV-1 activation in T-cells. Febs Letters 304(2-3): 261-264
Downward, J.; de Gunzburg, J.; Riehl, R.; Weinberg, R.A. 1988: P21ras-induced responsiveness of phosphatidylinositol turnover to bradykinin is a receptor number effect. Proceedings of the National Academy of Sciences of the United States of America 85(16): 5774-5778
Myrdal, S.E.; Auersperg, N. 1985: P21ras. Heterogeneous localization in transformed cells. Experimental Cell Research 159(2): 441-450
Cichowski, K.; McCormick, F.; Brugge, J.S. 1992: P21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets. Journal of Biological Chemistry 267(8): 5025-5028
Zazopoulos, E.; Sodroski, J.G.; Haseltine, W.A. 1990: P21rex protein of HTLV-1. Journal of Acquired Immune Deficiency Syndromes 3(12): 1135-1139
Ostvold, A.C.; Hullstein, I.; Sletten, K. 1992: P23, a novel mammalian nucleic acid-binding protein with homology to the yeast ribosomal protein YL43. Febs Letters 298(2-3): 219-222
Wei, C.; Lutz, R.; Sinensky, M.; Macara, I.G. 1992: P23rab2, a ras-like GTPase with a -GGGCC C-terminus, is isoprenylated but not detectably carboxymethylated in NIH3T3 cells. Oncogene 7(3): 467-473
Stickler, M.C.; Sharpe, S.; Zolla-Pazner, S. 1992: P24 antibody production in p24 antibody-negative HIV-infected subjects. Viral Immunology 5(2): 123-132
Ando, Y.; Hashimoto, H.; Kakimoto, K.; Tanigawa, T.; Moriyama, I.; Ichijo, M. 1990: P24 protein of a human T-lymphotropic virus type-i (HTLV-I) producing cell line (TCL-Kan) reacts with some normal pregnant women's sera. Nihon Sanka Fujinka Gakkai Zasshi 42(9): 1251-1255
Kutuzov, M.A.; Shmukler, B.E.; Suslov, O.N.; Zargarov, A.A.; Abdulaev, N.G. 1992: P26--a calcium binding protein from photoreceptor cells in the bovine retina: primary structure and expression in E. coli. Bioorganicheskaia Khimiia 18(5): 623-634
Jennette, J.C.; Feldman, J.D. 1978: P30-Anti-p30 immune complexes: intravascular clearance and extravascular sequestration in rats bearing Moloney sarcoma. Journal of Immunology 121(5): 1696-1700
Draetta, G.; Brizuela, L.; Beach, D. 1988: P34, a protein kinase involved in cell cycle regulation in eukaryotic cells. Advances in Experimental Medicine and Biology 231: 453-457
Enoch, T.; Peter, M.; Nurse, P.; Nigg, E.A. 1991: P34cdc2 acts as a lamin kinase in fission yeast. Journal of Cell Biology 112(5): 797-807
John, P.C.; Sek, F.J.; Carmichael, J.P.; McCurdy, D.W. 1990: P34cdc2 homologue level, cell division, phytohormone responsiveness and cell differentiation in wheat leaves. Journal of Cell Science 97: 627-630
Bailly, E.; Dorée, M.; Nurse, P.; Bornens, M. 1989: P34cdc2 is located in both nucleus and cytoplasm; part is centrosomally associated at G2/M and enters vesicles at anaphase. EMBO Journal 8(13): 3985-3995
Ferris, D.K.; White, G.A.; Kelvin, D.J.; Copeland, T.D.; Li, C.C.; Longo, D.L. 1991: P34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinase. Cell Growth and Differentiation: the Molecular Biology Journal of the American Association for Cancer Research 2(7): 343-349
Rattner, J.B.; Lew, J.; Wang, J.H. 1990: P34cdc2 kinase is localized to distinct domains within the mitotic apparatus. Cell Motility and the Cytoskeleton 17(3): 227-235
Molloy, S.; Little, M. 1992: P34cdc2 kinase-mediated release of lamins from nuclear ghosts is inhibited by cAMP-dependent protein kinase. Experimental Cell Research 201(2): 494-499
Sola, M.M.; Langan, T.; Cohen, P. 1991: P34cdc2 phosphorylation sites in histone H1 are dephosphorylated by protein phosphatase 2A1. Biochimica et Biophysica Acta 1094(2): 211-216
Jans, D.A.; Ackermann, M.J.; Bischoff, J.R.; Beach, D.H.; Peters, R. 1991: P34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. Journal of Cell Biology 115(5): 1203-1212
Pines, J.; Hunter, T. 1990: P34cdc2: the S and M kinase?. New Biologist 2(5): 389-401
Singh, B.; Hannink, M.; Donoghue, D.J.; Arlinghaus, R.B. 1986: P37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. Journal of Virology 60(3): 1148-1152
Haluska, F.G.; Huebner, K.; Croce, C.M. 1987: P380-8A 1.8 SaSs, a single copy clone 5' of c-myc at 8q24 which recognizes an Ssti polymorphism. Nucleic Acids Research 15(2): 865
Shuttleworth, J.; Godfrey, R.; Colman, A. 1990: P40MO15, a cdc2-related protein kinase involved in negative regulation of meiotic maturation of Xenopus oocytes. EMBO Journal 9(10): 3233-3240
L'Allemain, G.; Pouyssegur, J.; Weber, M.J. 1991: P42/mitogen-activated protein kinase as a converging target for different growth factor signaling pathways: use of pertussis toxin as a discrimination factor. Cell Regulation 2(8): 675-684
Lucotte, G.; Ngo, N.Y. 1985: P49f, a highly polymorphic probe, that detects Taq1 RFLPs on the human y chromosome. Nucleic Acids Research 13(22): 8285
Higgins, P.J.; Ryan, M.P.; Zeheb, R.; Gelehrter, T.D.; Chaudhari, P. 1990: P52 induction by cytochalasin D in rat kidney fibroblasts: homologies between p52 and plasminogen activator inhibitor type-1. Journal of Cellular Physiology 143(2): 321-329
Higgins, P.J.; Ryan, M.P. 1991: P52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells. Biochemical Journal 279: 883-890
Thompson, A.M.; Anderson, T.J.; Condie, A.; Prosser, J.; Chetty, U.; Carter, D.C.; Evans, H.J.; Steel, C.M. 1992: P53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters. International Journal of Cancer 50(4): 528-532
Harvey, D.M.; Levine, A.J. 1991: P53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes and Development 5(12b): 2375-2385
Metcalf, R.A.; Welsh, J.A.; Bennett, W.P.; Seddon, M.B.; Lehman, T.A.; Pelin, K.; Linnainmaa, K.; Tammilehto, L.; Mattson, K.; Gerwin, B.I. 1992: P53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Research 52(9): 2610-2615
Rogel, A.; Popliker, M.; Webb, C.G.; Oren, M. 1985: P53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Molecular and Cellular Biology 5(10): 2851-2855
Darzynkiewicz, Z.; Staiano-Coico, L.; Kunicka, J.E.; DeLeo, A.B.; Old, L.J. 1986: P53 content in relation to cell growth and proliferation in murine L1210 leukemia and normal lymphocytes. Leukemia Research 10(12): 1383-1389
Chopp, M.; Li, Y.; Zhang, Z.G.; Freytag, S.O. 1992: P53 expression in brain after middle cerebral artery occlusion in the rat. Biochemical and Biophysical Research Communications 182(3): 1201-1207
Harris, A.L. 1992: P53 expression in human breast cancer. Advances in Cancer Research 59: 69-88
Ohyama, K.; Segawa, K. 1991: P53 gene as a tumor suppressor gene. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(12): 1887-1899
Loda, M.; Giangaspero, F.; Badiali, M.; Capodieci, P.; Pession, A. 1992: P53 gene expression in medulloblastoma by quantitative polymerase chain reaction. Diagnostic Molecular Pathology: the American Journal of Surgical Pathology Part B 1(1): 36-44
Torigoe, S.; Shuin, T.; Kubota, Y.; Horikoshi, T.; Danenberg, K.; Danenberg, P.V. 1992: P53 gene mutation in primary human renal cell carcinoma. Oncology Research 4(11-12): 467-472
Brachman, D.G.; Hallahan, D.E.; Beckett, M.A.; Yandell, D.W.; Weichselbaum, R.R. 1991: P53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. Cancer Research 51(23 Part 1): 6393-6396
Tamura, G.; Maesawa, C.; Suzuki, Y.; Satodate, R.; Ishida, K.; Saito, K. 1992: P53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis. Japanese Journal of Cancer Research: Gann 83(6): 559-562
Matozaki, T.; Sakamoto, C.; Suzuki, T.; Matsuda, K.; Uchida, T.; Nakano, O.; Wada, K.; Nishisaki, H.; Konda, Y.; Nagao, M. 1992: P53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Research 52(16): 4335-4341
Mitsudomi, T.; Steinberg, S.M.; Nau, M.M.; Carbone, D.; D'Amico, D.; Bodner, S.; Oie, H.K.; Linnoila, R.I.; Mulshine, J.L.; Minna, J.D. 1992: P53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7(1): 171-180
Schlegel, U.; Rosenfeld, M.R.; Volkenandt, M.; Rosenblum, M.; Dalmau, J.; Furneaux, H. 1992: P53 gene mutations in primary lung tumors are conserved in brain metastases. Journal of Neuro-Oncology 14(2): 93-100
Santibáñez-Koref, M.F.; Birch, J.M.; Hartley, A.L.; Jones, P.H.; Craft, A.W.; Eden, T.; Crowther, D.; Kelsey, A.M.; Harris, M. 1991: P53 germline mutations in Li-Fraumeni syndrome. Lancet 338(8781): 1490-1491
Soini, Y.; Vähäkangas, K.; Nuorva, K.; Kamel, D.; Lane, D.P.; Pääkkö, P. 1992: p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. Journal of Pathology 168(1): 29-33
Hall, P.A.; Ray, A.; Lemoine, N.R.; Midgley, C.A.; Krausz, T.; Lane, D.P. 1991: P53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet 338(8765): 513
Heyderman, E.; Dagg, B. 1991: P53 immunostaining in benign breast disease. Lancet 338(8781): 1532
Lane, D.P. 1987: P53 in Paris, an oncogene comes of age. Oncogene 1(3): 241-242
Stürzbecher, H.W.; Maimets, T.; Chumakov, P.; Brain, R.; Addison, C.; Simanis, V.; Rudge, K.; Philp, R.; Grimaldi, M.; Court, W. 1990: P53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene 5(6): 795
Milner, J.; Gamble, J.; Cook, A. 1989: P53 is associated with a 35 kD protein in cells transformed by simian virus 40. Oncogene 4(5): 665-668
Milner, J.; Cook, A.; Mason, J. 1990: P53 is associated with p34cdc2 in transformed cells. EMBO Journal 9(9): 2885-2889
Kress, S.; König, J.; Schweizer, J.; Löhrke, H.; Bauer-Hofmann, R.; Schwarz, M. 1992: P53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors. Molecular Carcinogenesis 6(2): 148-158
Moore, M.; Teresky, A.K.; Levine, A.J.; Seiberg, M. 1992: P53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. Journal of Virology 66(2): 641-649
Scorsone, K.A.; Zhou, Y.Z.; Butel, J.S.; Slagle, B.L. 1992: P53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Research 52(6): 1635-1638
El Rouby, S.; Bayona, W.; Pisharody, S.M.; Newcomb, E.W. 1992: P53 mutations in B-cell chronic lymphocytic leukemia. Current Topics in Microbiology and Immunology 182: 313-317
Brathwaite, O.; Bayona, W.; Newcomb, E.W. 1992: P53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea. Cancer Research 52(13): 3791-3795
Suzuki, H.; Takahashi, T.; Kuroishi, T.; Suyama, M.; Ariyoshi, Y.; Takahashi, T.; Ueda, R. 1992: P53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Research 52(3): 734-736
Callahan, R. 1992: P53 mutations, another breast cancer prognostic factor. Journal of the National Cancer Institute 84(11): 826-827
Lehman, T.A.; Bennett, W.P.; Metcalf, R.A.; Welsh, J.A.; Ecker, J.; Modali, R.V.; Ullrich, S.; Romano, J.W.; Appella, E.; Testa, J.R. 1991: P53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Research 51(15): 4090-4096
Sauter, E.R.; Ridge, J.A.; Gordon, J.; Eisenberg, B.L. 1992: P53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base. American Journal of Surgery 164(6): 651-653
Kerns, B.J.; Jordan, P.A.; Moore, M.B.; Humphrey, P.A.; Berchuck, A.; Kohler, M.F.; Bast, R.C.; Iglehart, J.D.; Marks, J.R. 1992: P53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 40(7): 1047-1051
Bártková, J.; Bártek, J.; Lukás, J.; Vojtĕsek, B.; Stasková, Z.; Rejthar, A.; Kovarík, J.; Midgley, C.A.; Lane, D.P. 1991: P53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. International Journal of Cancer 49(2): 196-202
Kainz, C.; Gitsch, G.; Joura, E.; Breitenecker, G. 1992: P53 protein in patients with Figo stage III cervix cancer. Gynakologisch-Geburtshilfliche Rundschau 32(Suppl 1): 116
Mitsudomi, T.; Chiba, I. 1992: P53 tumor suppressor gene and its clinical significance. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 37(9): 1491-1505
Mellon, K.; Thompson, S.; Charlton, R.G.; Marsh, C.; Robinson, M.; Lane, D.P.; Harris, A.L.; Horne, C.H.; Neal, D.E. 1992: P53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. Journal of Urology 147(2): 496-499
Ross, D.W. 1990: P53--a candidate antioncogene. Archives of Pathology and Laboratory Medicine 114(4): 432
Nesland, J.M. 1991: P53--a gene to mark itself. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(22): 2721-2722
Frey, A.B.; Levine, A.J. 1989: P53-plus-ras-transformed rat embryo fibroblasts express tumor-specific transplantation antigen activity which is shared by independently transformed cells. Journal of Virology 63(12): 5440-5444
Blume, E. 1991: P53: how a tumor suppressor works. Journal of the National Cancer Institute 83(3): 158-160
Lane, D.P.; Benchimol, S. 1990: p53: oncogene or anti-oncogene?. Genes and Development 4(1): 1-8
Froussard, P.; Chastagner, P.; Sommé, G.; Abadie, A.; Greene, W.; Thèze, J.; Longacre, S. 1988: P55 IL-2 receptor mRNA precursors in murine T lymphocyte nuclei. Journal of Immunology 141(4): 1358-1364
Millar, J.B.; Blevitt, J.; Gerace, L.; Sadhu, K.; Featherstone, C.; Russell, P. 1991: P55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. Proceedings of the National Academy of Sciences of the United States of America 88(23): 10500-10504
Collins, T.L.; Uniyal, S.; Shin, J.; Strominger, J.L.; Mittler, R.S.; Burakoff, S.J. 1992: P56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. Journal of Immunology 148(7): 2159-2162
Louie, R.R.; King, C.S.; MacAuley, A.; Marth, J.D.; Perlmutter, R.M.; Eckhart, W.; Cooper, J.A. 1988: P56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen. Journal of Virology 62(12): 4673-4679
Srinivas, P.R.; Hutchcroft, J.E.; Aube, B.D.; Harrison, M.L. 1992: P56lck stably associates with a 115 kDa substrate. Biochemical and Biophysical Research Communications 186(1): 537-542
Litwin, C.M.; Gendreau, M.; Wang, J.H. 1992: P56lyn catalyzes a reversible autophosphorylation reaction and a nucleoside diphosphate kinase reaction. Febs Letters 309(3): 275-278
Simek, S.; Rice, N.R. 1988: P59v-rel, the transforming protein of reticuloendotheliosis virus, is complexed with at least four other proteins in transformed chicken lymphoid cells. Journal of Virology 62(12): 4730-4736
Parsons, S.J.; Creutz, C.E. 1986: P60c-src activity detected in the chromaffin granule membrane. Biochemical and Biophysical Research Communications 134(2): 736-742
Grandori, C.; Hanafusa, H. 1988: P60c-src is complexed with a cellular protein in subcellular compartments involved in exocytosis. Journal of Cell Biology 107(6 Part 1): 2125-2135
Mochly-Rosen, D.; Miller, K.G.; Scheller, R.H.; Khaner, H.; Lopez, J.; Smith, B.L. 1992: P65 fragments, homologous to the C2 region of protein kinase C, bind to the intracellular receptors for protein kinase C. Biochemistry 31(35): 8120-8124
Wong, W.W.; Fearon, D.T. 1985: P65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. Journal of Immunology 134(6): 4048-4056
Zhang, J.Y.; Ebisuzaki, K. 1989: P66 an in vivo target for poly(ADP-ribosyl)ation co-purifies with poly(ADP-ribose) polymerase. Biochemical and Biophysical Research Communications 165(2): 631-636
Gauthier-Rouvière, C.; Cavadore, J.C.; Blanchard, J.M.; Lamb, N.J.; Fernandez, A. 1991: P67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regulation 2(7): 575-588
Benton, B.M.; Berrios, S.; Fisher, P.A. 1988: P75, a polypeptide component of karyoskeletal protein-enriched fractions associated with transcriptionally active loci of Drosophila melanogaster polytene chromosomes. Molecular and Cellular Biology 8(5): 1877-1886
Ohnishi, H.; Kamano, H.; Tanaka, T.; Okabe, A.; Irino, S. 1990: P75c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation. Leukemia Research 14(5): 423-432
Aleixandre, C.; Miller, D.A.; Mitchell, A.R.; Warburton, D.A.; Gersen, S.L.; Disteche, C.; Miller, O.J. 1987: P82H identifies sequences at every human centromere. Human Genetics 77(1): 46-50
Tallarida, R.J.; Cowan, A.; Adler, M.W. 1979: PA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sciences 25(8): 637-654
O'Donnell, S.R.; Barnett, C.J. 1988: PA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. British Journal of Pharmacology 94(2): 437-442
Fratini, A.; Baker, E.G.; Callen, D.F.; Reeders, S.; Hyland, V.J.; Sutherland, G.R. 1988: PACHF1.1 [D16S8] detects a common PvuIi RFLP and maps at 16p13.3----16p13.11. Nucleic Acids Research 16(18): 9065
Martinez, E.; Bartolomé, B.; de la Cruz, F. 1988: PACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68(1): 159-162
Dasmahapatra, B.; Rozhon, E.J.; Schwartz, J. 1987: PBD7, a novel cell-free expression vector with efficient translation initiation signal. Nucleic Acids Research 15(9): 3933
Michaeli, T.; Prives, C. 1987: PBR322 DNA inhibits simian virus 40 gene expression in Xenopus laevis oocytes. Nucleic Acids Research 15(4): 1579-1594
Tully, D.B.; Cidlowski, J.A. 1987: PBR322 contains glucocorticoid regulatory element DNA consensus sequences. Biochemical and Biophysical Research Communications 144(1): 1-10
Sutcliffe, J.G. 1978: PBR322 restriction map derived from the DNA sequence: accurate DNA size markers up to 4361 nucleotide pairs long. Nucleic Acids Research 5(8): 2721-2728
Berg, C.M.; Liu, L.; Coon, M.; Strausbaugh, L.D.; Gray, P.; Vartak, N.B.; Brown, M.; Talbot, D.; Berg, D.E. 1989: PBR322-derived multicopy plasmids harboring large inserts are often dimers in Escherichia coli K-12. Plasmid 21(2): 138-141
Alting-Mees, M.A.; Short, J.M. 1989: PBluescript II: gene mapping vectors. Nucleic Acids Research 17(22): 9494
Kleinzeller, A.; Booz, G.W.; Mills, J.W.; Ziyadeh, F.N. 1990: PCMBS-induced swelling of dogfish (Squalus acanthias) rectal gland cells: role of the Na+,K(+)-ATPase and the cytoskeleton. Biochimica et Biophysica Acta 1025(1): 21-31
Luirink, J.; Clark, D.M.; Ras, J.; Verschoor, E.J.; Stegehuis, F.; de Graaf, F.K.; Oudega, B. 1989: PCloDF13-encoded bacteriocin release proteins with shortened carboxyl-terminal segments are lipid modified and processed and function in release of cloacin DF13 and apparent host cell lysis. Journal of Bacteriology 171(5): 2673-2679
Ramesh, A.; Srikumari, C.R.; Ferrell, R.E. 1991: PDL32b (D12S7) detects a 2-allele Psti polymorphism. Nucleic Acids Research 19(17): 4789
Spurdle, A.B.; Jenkins, T. 1990: PDP1007, detects an X polymorphism with HindIIi in negroids at the ZFX locus. Nucleic Acids Research 18(11): 3430
Dente, L.; Cortese, R. 1987: PEMBL: a new family of single-stranded plasmids for sequencing DNA. Methods in Enzymology 155: 111-119
Forman, B.M.; Samuels, H.H. 1991: PEXPRESS: a family of expression vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro. Gene 105(1): 9-15
Goodfellow, P.J.; Duncan, A.M.; Simpson, N.E.; White, B.N. 1986: PG95 alpha 1-7dIII/RI, a single copy clone at Xp11.4 which recognises a Taqi polymorphism (DXS209). Nucleic Acids Research 14(21): 8693
Ron, D.; Dressler, H. 1992: PGSTag--a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. Biotechniques 13(6): 866-869
Laufer, R.; Gilon, C.; Chorev, M.; Selinger, Z. 1986: PGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype. Journal of Medicinal Chemistry 29(7): 1284-1288
Ackerman, W.E.; Juneja, M.M. 1990: PH adjustment of 0.5% bupivacaine. Regional Anesthesia 15(3): 152
Redick, L.F. 1987: PH adjustment of chloroprocaine solutions. Anesthesia and Analgesia 66(3): 286
Peterfreund, R.A.; Datta, S.; Ostheimer, G.W. 1989: PH adjustment of local anesthetic solutions with sodium bicarbonate: laboratory evaluation of alkalinization and precipitation. Regional Anesthesia 14(6): 265-270
Ikuta, P.T.; Raza, S.M.; Durrani, Z.; Vasireddy, A.R.; Winnie, A.P.; Masters, R.W. 1989: PH adjustment schedule for the amide local anesthetics. Regional Anesthesia 14(5): 229-235
Harris, M.G.; Torres, J.; Tracewell, L. 1988: PH and H2O2 concentration of hydrogen peroxide disinfection systems. American Journal of Optometry and Physiological Optics 65(7): 527-535
Hummel, K.; Winkler, U.; Hennebach, U. 1990: PH and IgA determination of nasal secretions--possible use in occupational medicine-rhinologic diagnosis in relation to function. Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 36(6): 320-322
Nuñez-Vergara, L.J.; Lemus, I.R.; Squella, J.A. 1988: PH and P.E.G.-400 effects on flucloxacillin absorption. General Pharmacology 19(3): 447-449
Bolton, D.T. 1985: PH and atracurium. British Journal of Anaesthesia 57(5): 545
Shapiro, B.A. 1989: PH and blood gas measurements: discerning innovation from sophistication. Critical Care Medicine 17(9): 966
Zhang, J.X.; Halling, P.J. 1990: PH and buffering in the bicinchoninic acid (4,4'-dicarboxy-2,2'-biquinoline) protein assay. Analytical Biochemistry 188(1): 9-10
Thoma, W.J.; Uğurbil, K. 1988: PH and compartmentation of isolated perfused rat liver studied by 31P and 19F NMR. Nmr in Biomedicine 1(2): 95-100
Brorson, J.E.; Larsson, P. 1985: PH and incubation atmosphere influence erythromycin activity against Branhamella catarrhalis. Journal of Antimicrobial ChemoTherapy 15(5): 644-645
Denu, J.M.; Fitzpatrick, P.F. 1992: PH and kinetic isotope effects on the reductive half-reaction of D-amino acid oxidase. Biochemistry 31(35): 8207-8215
Cadet, F.; Meunier, J.C. 1988: PH and kinetic studies of chloroplast sedoheptulose-1,7-bisphosphatase from spinach (Spinacia oleracea). Biochemical Journal 253(1): 249-254
Peerschke, E.I. 1985: PH and magnesium alter 45calcium binding to platelets at sites other than glycoproteins i or IIb/IIIa. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 179(2): 232-239
Lacapère, J.J.; Bennett, N.; Dupont, Y.; Guillain, F. 1990: PH and magnesium dependence of ATP binding to sarcoplasmic reticulum ATPase. Evidence that the catalytic ATP-binding site consists of two domains. Journal of Biological Chemistry 265(1): 348-353
Baraka, A. 1992: PH and muscle relaxants. Anesthesiology 76(2): 320
McIntyre, K.A.; Galgiani, J.N. 1989: PH and other effects on the antifungal activity of cilofungin (LY121019). Antimicrobial Agents and ChemoTherapy 33(5): 731-735
Nakamura, J. 1989: PH and temperature resolve the kinetics of two pools of calcium bound to the sarcoplasmic reticulum Ca2+ -ATPase. Journal of Biological Chemistry 264(29): 17029-17031
Le Mee, J.; Bellasfar, G.; Branger, C.; Duchene, P.; Langonnet, F.; Fekete, F. 1987: PH and the bacteriology of gastroplasties after esogastric resection. Journal de Chirurgie 124(1): 10-13
Helgeland, K. 1985: PH and the effect of NH4Cl on human gingival fibroblasts. Scandinavian Journal of Dental Research 93(1): 39-45
Bradlow, H.L.; Breed, C.N.; Nisselbaum, J.; Fleisher, M.; Schwartz, M.K. 1987: PH as a marker of breast cyst fluid biochemical type. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 13(4): 331-334
Martin, R.B. 1988: PH as a variable in free zinc ion concentration from zinc-containing lozenges. Antimicrobial Agents and ChemoTherapy 32(4): 608-609
Pontasch, M.J.; Brodell, R.T. 1988: PH buffering of local anesthetic solutions: marked reduction in pain with local infiltration of anesthetic solutions. Journal of Dermatologic Surgery and Oncology 14(6): 672
Konstantinov, A.A.; Capitanio, N.; Vygodina, T.V.; Papa, S. 1992: PH changes associated with cytochrome c oxidase reaction with H2O2. Protonation state of the peroxy and oxoferryl intermediates. Febs Letters 312(1): 71-74
Sissons, C.H.; Cutress, T.W. 1988: PH changes during simultaneous metabolism of urea and carbohydrate by human salivary bacteria in vitro. Archives of Oral Biology 33(8): 579-587
Lökken, P.; Birkeland, J.M.; Sannes, E. 1975: PH changes in dental plaque caused by sweetened, iron-containing liquid medicine. Scandinavian Journal of Dental Research 83(5): 279-283
Baumgärtl, H.; Zimelka, W.; Lübbers, D.W. 1990: PH changes in front of the hydrogen generating electrode during measurements with an electrolytic hydrogen clearance sensor. Advances in Experimental Medicine and Biology 277: 107-113
Haimovici, A.; Hremiuc, M.; Vătăman, R. 1975: PH changes in pulpitis. Revista de Chirurgie Oncologie Radiologie O. R. L. Oftalmologie Stomatologie. Seria: Stomatologie 22(3): 179-182
Kozlov, V.K.; Markosian, R.A.; Filatova, L.V. 1985: PH changes in the matrix of serotonin organelles of stimulated thrombocytes. Biulleten' Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn SSSR 8(1): 77-82
Thygesen, J.E.; Jensen, O.L. 1987: PH changes of the tear fluid in the conjunctival sac during postoperative inflammation of the human eye. Acta Ophthalmologica 65(2): 134-136
Zgraggen, U.; Graf, H. 1975: PH changes underneath complete maxillary dentures. Schweizerische Monatsschrift für Zahnheilkunde 85(8): 797-812
Demas, G.N. 1989: PH consistency and stability of contact lens solutions. Journal of the American Optometric Association 60(10): 732-734
Lenzen, C.; Soboll, S.; Sies, H.; Häussinger, D. 1987: PH control of hepatic glutamine degradation. Role of transport. European Journal of Biochemistry 166(2): 483-488
Zaitsu, A. 1991: PH correction. Kokyu to Junkan. Respiration and Circulation 39(10): 993-999
Hobish, M.K.; Powers, D.A. 1986: PH dependence of 2,3-diphosphoglycerate binding to human hemoglobin A0 at 21.5 degrees C. Proteins 1(2): 164-175
Guerquin-Kern, J.L.; Leteurtre, F.; Croisy, A.; Lhoste, J.M. 1991: PH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy. Cancer Research 51(20): 5770-5773
Wang, F.; Sampogna, R.V.; Ware, B.R. 1989: PH dependence of actin self-assembly. Biophysical Journal 55(2): 293-298
Brouillette, C.G.; Muccio, D.D.; Finney, T.K. 1987: PH dependence of bacteriorhodopsin thermal unfolding. Biochemistry 26(23): 7431-7438
Farnum, M.; Palcic, M.; Klinman, J.P. 1986: PH dependence of deuterium isotope effects and tritium exchange in the bovine plasma amine oxidase reaction: a role for single-base catalysis in amine oxidation and imine exchange. Biochemistry 25(8): 1898-1904
Ohshima, H.; Kondo, T. 1988: PH dependence of electrostatic interaction between ion-penetrable membranes. Biophysical Chemistry 32(2-3): 161-166
Savitsky, A.P.; Lopatin, K.V.; Golubeva, N.A.; Poroshina MYu; Chernyaeva, E.B.; Stepanova, N.V.; Solovieva, L.I.; Lukyanets, E.A. 1992: PH dependence of fluorescence and absorbance spectra of free sulphonated aluminium phthalocyanine and its conjugate with monoclonal antibodies. Journal of Photochemistry and Photobiology. B Biology 13(3-4): 327-333
Nall, B.T.; Osterhout, J.J.; Ramdas, L. 1988: PH dependence of folding of iso-2-cytochrome c. Biochemistry 27(19): 7310-7314
Oldendorf, W.H.; Crane, P.D.; Braun, L.D.; Gosschalk, E.A.; Diamond, J.M. 1988: PH dependence of histidine affinity for blood-brain barrier carrier transport systems for neutral and cationic amino acids. Journal of Neurochemistry 50(3): 857-861
Endo, T.; Ueda, T.; Yamada, H.; Imoto, T. 1987: PH dependence of individual tryptophan N-1 hydrogen exchange rates in lysozyme and its chemically modified derivatives. Biochemistry 26(7): 1838-1845
Ishikawa, S.; Okada, K.; Saito, T. 1992: PH dependence of inhibition of arginine vasopressin-induced adenosine 3',5'-monophosphate production by cellular sodium depletion in rat renal inner medullary collecting duct cells in culture. Endocrinology 130(1): 17-22
Lin, Y.; Fusek, M.; Lin, X.; Hartsuck, J.A.; Kezdy, F.J.; Tang, J. 1992: PH dependence of kinetic parameters of pepsin, rhizopuspepsin, and their active-site hydrogen bond mutants. Journal of Biological Chemistry 267(26): 18413-18418
Kennedy, K.A.; McGurl, J.D.; Leondaridis, L.; Alabaster, O. 1985: PH dependence of mitomycin C-induced cross-linking activity in EMT6 tumor cells. Cancer Research 45(8): 3541-3547
Berghout, A.; Raida, M.; Romano, L.; Passow, H. 1985: PH dependence of phosphate transport across the red blood cell membrane after modification by dansyl chloride. Biochimica et Biophysica Acta 815(2): 281-286
Fromm, M.; Tykocinski, M.; Schulzke, J.D.; Hegel, U.; Bentzel, C.J. 1990: PH dependence of protamine action on apical membrane permeability in Necturus gallbladder epithelium. Biochimica et Biophysica Acta 1027(2): 179-184
Bonneau, R.; Pottier, R.; Bagno, O.; Joussot-Dubien, J. 1975: PH dependence of singlet oxygen production in aqueous solutions using thiazine dyes as photosensitizers. Photochemistry and Photobiology 21(3): 159-163
Pottier, R.; Bonneau, R.; Joussot-Dubien, J. 1975: PH dependence of singlet oxygen production in aqueous solutions using toluidine blue as a photosensitizer. Photochemistry and Photobiology 22(1-2): 59-61
Presland, J.P.; Strange, P.G. 1991: PH dependence of sulpiride binding to D2 dopamine receptors in bovine brain. Biochemical Pharmacology 41(6-7): R9-12
Cook, P.F.; Hara, S.; Nalabolu, S.; Schnackerz, K.D. 1992: PH dependence of the absorbance and 31P NMR spectra of O-acetylserine sulfhydrylase in the absence and presence of O-acetyl-L-serine. Biochemistry 31(8): 2298-2303
Colman, P.D.; Blanchet, S.P.; Chow, E.; Feigelson, P. 1975: PH dependence of the cooperative interactions and conformation of tryptophan oxygenase. Journal of Biological Chemistry 250(16): 6208-6213
Brady, K.; Liang, T.C.; Abeles, R.H. 1989: PH dependence of the inhibition of chymotrypsin by a peptidyl trifluoromethyl ketone. Biochemistry 28(23): 9066-9070
Betz, A.; Hofsteenge, J.; Stone, S.R. 1992: PH dependence of the interaction of hirudin with thrombin. Biochemistry 31(4): 1168-1172
Pollack, R.M.; Bantia, S.; Bounds, P.L.; Koffman, B.M. 1986: PH dependence of the kinetic parameters for 3-oxo-delta 5-steroid isomerase. Substrate catalysis and inhibition by (3S)-spiro[5 alpha-androstane-3,2'-oxiran]-17-one. Biochemistry 25(8): 1905-1911
Cho, Y.K.; Cook, P.F. 1989: PH dependence of the kinetic parameters for the pyrophosphate-dependent phosphofructokinase reaction supports a proton-shuttle mechanism. Biochemistry 28(10): 4155-4160
Deville-Bonne, D.; Bourgain, F.; Garel, J.R. 1991: PH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli. Biochemistry 30(23): 5750-5754
Miyake, T.; Inoue, S.; Ikeda, K.; Teshima, K.; Samejima, Y.; Omori-Satoh, T. 1989: PH dependence of the reaction rate of his 48 with p-bromophenacyl bromide and of the binding constant to Ca2+ of the monomeric forms of intact and alpha-NH2 modified phospholipases A2 from Trimeresurus flavoviridis. Journal of Biochemistry 105(4): 565-572
Mulkerrin, M.G.; Wetzel, R. 1989: PH dependence of the reversible and irreversible thermal denaturation of gamma interferons. Biochemistry 28(16): 6556-6561
Koval, T.M.; Suppes, D.L. 1990: PH dependency of cell attachment and growth at both clonal and subculture densities of cultured lepidopteran cells. In Vitro Cellular and Developmental Biology; Journal of the Tissue Culture Association 26(7): 665-670
Yamauchi, H.; Sasano, M.; Iso, T. 1988: PH dependency of effect of topically applied dipivefrine hydrochloride on intraocular pressure and pupil size in rabbits: comparative studies with epinephrine. Japanese Journal of Ophthalmology 32(2): 187-195
Theis, J.G.; Dellweg, H.; Perzborn, E.; Gross, R. 1992: PH dependency of the binding of [3H]BAY U 3405 and various non-labelled ligands to the thromboxane A2/prostaglandin H2 receptor of human platelet membranes. European Journal of Pharmacology 226(2): 149-156
Turnbull, J.; Cleland, W.W.; Morrison, J.F. 1991: PH dependency of the reactions catalyzed by chorismate mutase-prephenate dehydrogenase from Escherichia coli. Biochemistry 30(31): 7777-7782
Hölzemann, G.; Pachler, K.G. 1989: PH dependent conformation of physalaemin. International Journal of Peptide and Protein Research 34(2): 139-147
Kim, Y.; Shields, J.E. 1992: PH dependent conformational changes in the T- and R-states of insulin in solution: circular dichroic studies in the pH range of 6 to 10. Biochemical and Biophysical Research Communications 186(2): 1115-1120
Brasseur, R.; Cabiaux, V.; Falmagne, P.; Ruysschaert, J.M. 1986: PH dependent insertion of a diphtheria toxin B fragment peptide into the lipid membrane: a conformational analysis. Biochemical and Biophysical Research Communications 136(1): 160-168
Fujikawa, K.; Numasaki, H.; Kobayashi, M.; Sugano, N.; Tomura, S.; Murai, S. 1989: PH determination in human crevicular fluids. Examination of the pH meter and evaluation of the correlation between pH level and clinical findings or the microflora in each periodontal pocket. Nihon Shishubyo Gakkai Kaishi 31(1): 241-248
Pinzauti, S.; Papeschi, G.; La Porta, E. 1986: PH determination of APF gels by an iridium electrode. Caries Research 20(5): 429-432
Ban, S.; Fukui, H.; Mori, S.; Hasegawa, J. 1985: PH determinations on the surface of luting cements. I. a test method. Dental Materials Journal 4(2): 208-215
Ban, S.; Iwai, M.; Hasegawa, J. 1986: PH determinations on the surface of luting cements. II. Effects of test conditions. Dental Materials Journal 5(2): 193-201
Ban, S.; Hasegawa, J.; Lacy, A.M. 1986: PH determinations on the surface of luting cements. III. pH change and setting reaction of zinc phosphate cements. Dental Materials Journal 5(2): 202-210
Thistlethwaite, A.J.; Leeper, D.B.; Moylan, D.J.; Nerlinger, R.E. 1985: PH distribution in human tumors. International Journal of Radiation Oncology Biology Physics 11(9): 1647-1652
Fraser, R.H.; Inglis, G.; Mitchell, R. 1986: PH effect on anti-M and anti-N reactivity. Transfusion 26(1): 118-119
Bowman, H.S. 1985: PH effect on anti-N reactivity. Transfusion 25(1): 86-87
Fogh-Andersen, N.; Thomsen, J.K.; Foldager, N.; Siggaard-Andersen, O. 1990: PH effect on the COHb absorption spectrum: importance for calibration of the OSM3 and measurement of circulating hemoglobin and blood volume. Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum 203: 247-252
Christensen, U. 1975: PH effects in plasmin-catalysed hydrolysis of alpha-N-benzoyl-L-arginine compounds. Biochimica et Biophysica Acta 397(2): 459-467
Lieske, C.N.; Gessner, C.E.; Gepp, R.T.; Clark, J.H.; Meyer, H.G.; Broomfield, C.A. 1990: PH effects in the spontaneous reactivation of phosphinylated acetylcholinesterase. Life Sciences 46(17): 1189-1196
Johnson, R.M. 1985: PH effects on red cell deformability. Blood Cells 11(2): 317
Vatier, J.; Vitre, M.T.; Vallot, T.; Mignon, M. 1990: PH gradient support and antacid action of gastroesophageal coating agents. in vitro pharmacologic study using a model of "the artificial stomach". Gastroenterologie Clinique et Biologique 14(5): 414-422
Quamme, G.A.; Walker, J.J.; Yan, T.S. 1989: PH gradient-stimulated phosphate transport in outer medullary brush-border membranes. American Journal of Physiology 257(4 Part 2): F639-F648
Cullis, P.R.; Bally, M.B.; Madden, T.D.; Mayer, L.D.; Hope, M.J. 1991: pH gradients and membrane transport in liposomal systems. Trends in Biotechnology 9(8): 268-272
Celentano, F.C.; Tonani, C.; Fazio, M.; Gianazza, E.; Righetti, P.G. 1988: PH gradients generated by polyprotic buffers. I. Theory and computer simulation. Journal of Biochemical and Biophysical Methods 16(2-3): 109-128
Righetti, P.G.; Fazio, M.; Tonani, C.; Gianazza, E.; Celentano, F.C. 1988: PH gradients generated by polyprotic buffers. II. Experimental validation. Journal of Biochemical and Biophysical Methods 16(2-3): 129-140
Turnberg, L.A. 1985: PH gradients in the gastro-duodenal mucous gel. Gastroenterologie Clinique et Biologique 9(12 Part 2): 13-15
Törnquist, K.; Tashjian, A.H. 1992: PH homeostasis in pituitary GH4C1 cells: basal intracellular pH is regulated by cytosolic free Ca2+ concentration. Endocrinology 130(2): 717-725
La Cour, M. 1991: PH homeostasis in the frog retina: the role of Na+:HCO3- co-transport in the retinal pigment epithelium. Acta Ophthalmologica 69(4): 496-504
Abrahamsen, J.; Norrie, B.; Andersen, P.K.; Stokke, D.B.; Nedergaard, O.A. 1990: PH in physiological salt solutions: direct measurements. Acta Anaesthesiologica Scandinavica 34(8): 616-618
Maiti, M.; Nandi, R. 1986: PH induced change of natural deoxyribonucleic acids as followed by circular dichroism. Indian Journal of Biochemistry and Biophysics 23(6): 322-325
Musarrat, J.; Ahmad, M. 1988: PH induced damage and repair in E. coli. Mutation Research 193(3): 219-227
Antoine, J.L.; Contreras, J.L.; Van Neste, D.J. 1989: PH influence of surfactant-induced skin irritation. a non-invasive, multiparametric study with sodium laurylsulfate. Dermatosen in Beruf und Umwelt. Occupation and Environment 37(3): 96-100
Yamamoto, T.; Tonomura, Y. 1975: PH jump-induced phosphorylation of adenosine diphosphate in thylakoidal membranes. Journal of Biochemistry 77(1?): 137-146
Maggioni, P.; De Fina, S.; Emanuelli, G.; Real, G.; d'Alonzo, U.; Rock, T. 1985: PH manometry with endoluminal transducer in the diagnosis of gastroesophageal reflux. Author's experience. Minerva Medica 76(8): 349-350
Rapellino, M.; Obert, R.; Oliaro, A.; Cannizzo, S.; Pecchio, F.; Adamo, M.R. 1986: PH measurement in the diagnosis of pleural exudates. Minerva Medica 77(38): 1713-1716
Bennett, J.R. 1987: PH measurement in the oesophagus. Bailliere's Clinical Gastroenterology 1(4): 747-767
Schuster, R.; Appelt, D.; Böhme, H.; Häcker, R.; Lauschke, G. 1986: PH measurement in tissue--a reliable criterion for the registration of acute arterial circulatory disorder in animal experiments. Zeitschrift für Experimentelle Chirurgie Transplantation und Kunstliche Organe: Organ der Sektion Experimentelle Chirurgie der Gesellschaft für Chirurgie der Ddr 19(1): 46-49
Thoma, W.J.; Steiert, J.G.; Crawford, R.L.; Uğurbil, K. 1986: PH measurements by 31p NMR in bacterial suspensions using phenyl phosphonate as a probe. Biochemical and Biophysical Research Communications 138(3): 1106-1109
Barbosa, J.; Sanz-Nebot, V. 1992: PH measurements in acetonitrile-water mixtures by use of a glass electrode. Journal of Pharmaceutical and Biomedical Analysis 10(10-12): 1047-1051
Gelfi, C.; Morelli, A.; Rovida, E.; Righetti, P.G. 1986: PH measurements in ultranarrow immobilized pH gradients. Journal of Biochemical and Biophysical Methods 13(2): 113-124
Visch, L.L.; Bergveld, P.; Lamprecht, W.; 's-Gravenmade, E.J. 1991: PH measurements with an ion sensitive field effect transistor in the mouth of patients with xerostomia. IEEE Transactions on Bio-Medical Engineering 38(4): 353-356
Pucacco, L.R.; Corona, S.K.; Jacobson, H.R.; Carter, N.W. 1986: PH microelectrode: modified Thomas recessed-tip configuration. Analytical Biochemistry 153(2): 251-261